Glossary
- ๊ฐ๋์ ์ฝ
- ๊ฐ๋
๋ชจ๋ธ
- ๊ฐ๋ณต์
- ๊ฐ์์์ฉ
- ๊ฐ์ธ๋ง์ถค์ฝ๋ฌผ
- ๊ฐ์ธ์๋ณ์ ๋ณด/ ๊ฐ์ธ์๋ณ์
- ๊ฐ๊ต์ํ
- ๊ฐ๊ตฌ๋ฉด๋ด์กฐ์ฌ
- ๊ฐ๊ธ
- ๊ฐ์์ฌ์ค๋ง
- ๊ฐ์์ํ
- ๊ฐ์ฐ์ค๋ถ์
- ๊ฐ์กฑ์ ๊ต์ก์ ๋ํ ๊ถ๋ฆฌ์ ์ฌ์ํ ๋ณดํธ๋ฒ
- ๊ฐํน์ํ
- ๊ฐ๋ง
- ๊ฐ๋ง์ข
์ฐฝ
- ๊ฐ๋งํผํ๋
- ๊ฐ์ ๋
ธ์ถ
- ๊ฐ์ ์ ์ด
- ๊ฐ๋ฏธ๋ฃ
- ๊ฐ์ผ๊ฒฝ๋ก
- ๊ฐ์ผ์ฑ ์ธ์
- ๊ฑด๊ฐ๊ธฐ๋ฅ์ํ
- ๊ฑด๊ฐ๊ธฐ๋ฅ์ํ ๊ธฐํ ์๋ฃ
- ๊ฑด๊ฐ๋ณด์กฐ์ํ
- ๊ฑด์กฐ๋ฌผ, ๊ณ ํ๋ฌผ
- ๊ฒ์ฌ๋ฅ๋ ฅ (์๋ จ๋) ํ๊ฐ
- ๊ฒ์ฌ๋ฅ๋ ฅํ๊ฐ/์๋ จ๋ํ๊ฐ
- ๊ฒ์ฆ
- ๊ฒ์ฆ๋ ์ํ๋ฒ
- ๊ฒ์ฆ๋ ํ์ฉ ๋ฒ์
- ๊ฒ์ฒด ์ฑ์ทจ ์ฃผ๊ธฐ
- ๊ฒ์ถํ๊ณ
- ๊ฒฉ๋ฆฌ
- ๊ฒฐ๊ณผ
- ๊ฒฐ์ ๋ก ์ ๋ชจ๋ธ
- ๊ฒฐ์ ๋ก ์ ๋ถ์
- ๊ฒฐํต๊ฒ์ฌ
- ๊ฒฝ๊ณ ํ๊ณ (๋ฐฐ์ง ์ถฉ์ )
- ๊ฒฝ๊ณ ํ๊ณ (ํ๊ฒฝ๋ชจ๋ํฐ๋ง)
- ๊ฒฝ๊ตฌ ๋
ธ์ถ
- ๊ฒฝ์ ๊ฐ๋ฐํ๋ ฅ๊ธฐ๊ตฌ
- ๊ฒฝ์ ๊ฐ๋ฐํ๋ ฅ๊ธฐ๊ตฌ ์ ์กฐ๋๋
ธ๋ฌผ์ง์์
๋ฐ
- ๊ฒฝ์ ๋งฅ
- ๊ฒฝํผ ํก์
- ๊ณํต์ค์ฐจ
- ๊ณ ๊ธฐํ
- ๊ณ ๋ณ์์ฑ ์กฐ๋ฅ์ธํ๋ฃจ์์
- ๊ณ ์๋น๊ตญ์ํ์
- ๊ณ ์ ์ก์ฒด ํฌ๋ก๋งํ ๊ทธ๋ํผ
- ๊ณ ์ด๋ • ์ ์์ ์ํ
- ๊ณฐํก์ด๋
์
- ๊ณต๊ธฐ์กฐํ์ฅ์น
- ๊ณต์ ๋ฐธ๋ฆฌ๋ฐ์ด์
- ๊ณต์ ๋ณด์กฐ์
- ๊ณต์ ์
- ๊ณต์ ํ ์
ํ์
- ๊ด๋ฆฌ ๊ตฌ์ญ
- ๊ด๋ฆฌ ์ํ
- ๊ด๋ฆฌ ์ ๋ต
- ๊ด๋ฆฌ๋ฒํธ
- ๊ด๋ฆฌ๋ฒํธ, ๋กํธ๋ฒํธ, ์ ์กฐ๋ฒํธ
- ๊ด๋
์ฑ
- ๊ด๋ฒ์ ํญ์์ ๋ด์ฑ์ด์ง๊ท
- ๊ดํํ์ฑ์์ฝํ
- ๊ต๋
- ๊ต๋ฝ(ไบค็ตก)
- ๊ต์
- ๊ต์ฐจ์ค์ผ, 2์ฐจ์ค์ผ
- ๊ต์ฐจ์ ๊ฒ, ์ ๋ฌธ๊ฐ ์ฌ์ฌ
- ๊ตํ์ ์
- ๊ตฌ๊ฐ์ ๋ง์๊ทน์ํ
- ๊ตฌ๋๋์
- ๊ตฌ์ ์ญ
- ๊ตญ๊ฐ๋
์ฑ๊ด๋ฆฌํ๋ก๊ทธ๋จ
- ๊ตญ๊ฐ๋
์ฑํ๋ก๊ทธ๋จ ๋์ฒด๋
์ฑ์คํํ๊ฐ์ค๊ฐ์ผํฐ
- ๊ตญ๊ฐ์ถํ์น์ธ
- ๊ตญ์๋ด์ฑ์ํ
- ๊ตญ์์๊ทน์ํ
- ๊ตญ์ ์์ฐ๊ตฌ๊ธฐ๊ด
- ๊ตญ์ ๊ณตํต๊ธฐ์ ๋ฌธ์
- ๊ตญ์ ๋ฐฉ์ฌ์ ๋ฐฉ์ด์์ํ
- ๊ตญ์ ๋ฒํธ์ฒด๊ณ
- ๊ตญ์ ๋น์ ๋ฆฌ๋ฐฉ์ฌ์ ๋ฐฉ์ด์์ํ
- ๊ตญ์ ์ํ๊ท๊ฒฉ
- ๊ตญ์ ์ํ๊ท๊ฒฉ์์ํ
- ๊ตญ์ ์ํ์์ ๋น๊ตญ์๋คํธ์ํฌ
- ๊ตญ์ ์คํ๋๋ฌผ๊ด๋ฆฌ์ธ์ฆํํ
- ๊ตญ์ ์์ฝํ๋ชจ๋ํฐ๋ง์ผํฐ
- ๊ตญ์ ์์๋ฐ์ดํฐ๊ตํํ์ค์ปจ์์์
- ๊ตญ์ ์์์ํ๋ฐ์ดํฐ๊ตํํ์ค์ปจ์์์
- ๊ตญ์ ์์ํ์กฐํํ์์ฒด
- ๊ตญ์ ์์ญ์ฌ๋ฌด๊ตญ
- ๊ตญ์ ์ ๊ธฐ๊ธฐ์ ์์ํ
- ๊ตญ์ ํ์คํ๊ธฐ๊ตฌ
- ๊ถ๊ณ ๋
ธ์ถ๊ธฐ์ค
- ๊ท๊ฒฉ, ๊ธฐ์ค, ์๋ฐฉ์
- ๊ทธ๋์ผ์๋ฒ
- ๊ทผ๊ฑฐ๋ฌธ์
- ๊ธ๋ ์ด์ง
- ๊ธ์ฑ๋
์ฑ
- ๊ธ์ฑ๋
์ฑ์ํ
- ๊ธ์ฑ๋
์ฑ์ฐธ๊ณ ๋
- ๊ธ์ฑ๋
ธ์ถ
- ๊ธฐ๊ด์๋ช
์ค๋ฆฌ์์ํ, ์์์ํ์ฌ์ฌ์์ํ
- ๊ธฐ๊ตฌ ๋ฑ์ ์ด๊ท ์๋
์ ๋ณด์กฐ์ฑ๋ถ
- ๊ธฐ๊ตฌ ๋ฑ์ ์ด๊ท ์๋
์ ์ ํจ์ฑ๋ถ
- ๊ธฐ๊ตฌ ๋ฐ ์ฉ๊ธฐ,ํฌ์ฅ
- ๊ธฐ๋ฅ์ฑ
- ๊ธฐ๋ฅ์ฑ ์๋ฃ
- ๊ธฐ๋ฅ์ฑ ์ธ์ ๋ฑ๊ธ
- ๊ธฐ๋ฅ์ฑ ํ์ฅํ
- ๊ธฐ๋ํผ๊ทธ
- ๊ธฐ๋ ์์ฐ๋ (์์จ)
- ๊ธฐ๋ก ์๋ณธ, ๋ง์คํฐ ๊ธฐ๋ก
- ๊ธฐ๋ฆฝ๋ถ๋ฅ ์
- ๊ธฐ์์ถฉํ
- ๊ธฐ์ ์ด์ ์ฌ๋ฌด๊ตญ
- ๊ธฐ์ค ์ผํ
- ๊ธฐ์ค๊ฐ
- ๊ธฐ์ค๋ฌผ์ง
- ๊ธฐ์ด์ ์ข
- ๊ธธํญ์์ฉ
- ๋์ผ
- ๋ํธ๋ก์ฌ๋ฏผ
- ๋ํธ๋กํธ๋
- ๋ค๊ธฐ๊ด
- ๋ค๋งค์ฒด ๋
ธ์ถ
- ๋ค๋ฐฉ ์ฌ๊ฑด
- ๋ค์ด์์ง๋
ผ
- ๋ค์ด์ฅ์ ๋ฅ
- ๋ค์ธํฌ ์๋ฌผ
- ๋ค์์ฑ
- ๋ค์คํด๋ก ํญ์ฒด
- ๋คํ๋ฐฉํฅ์กฑํํ์์
- ๋จ๊ณ์ ์ํ์ ๋ต
- ๋จ๊ธฐ ๋
ธ์ถ
- ๋จ์ผ๋ฌผ์ง
- ๋จ์ผ์ํ๋ฒ
- ๋จ์ผ์ผ๊ธฐ๋ณ์ด๊ตฐ / ๋จ์ผ์ผ๊ธฐ ๋คํ์ฑ
- ๋จ์ธํฌ ์๋ฌผ
- ๋จ์ธํฌ๋จ๋ฐฑ์ง
- ๋จํํฌ์ฌ๋
์ฑ์ํ
- ๋จํด๋ก ํญ์ฒด
- ๋น๋ฅ
- ๋์ฉ๋์ฃผ์ฌ์
- ๋์ฅ๊ท ๊ตฐ
- ๋์ฌ
- ๋์ฌ phaseโ
๋ฐ์
- ๋์ฌ phaseโ
ก ๋ฐ์
- ๋์ฌ์ฆํ๊ตฐ
- ๋์กฐ์ฝ
- ๋์ฒด๋ฌผ
- ๋์ฒด์ํ
- ๋ํ๊ฒ์ฒด
- ๋ํ๊ฒ์ฒด(์ํ์ฉ๊ฒ์ฒด) / ์ฐธ๊ณ ํ
- ๋ํ์ฑ
- ๋ํ๋ฏผ๊ตญ์ฝ์
- ๋ํ๋ฏผ๊ตญ์ฝ์ ์ธ ์์ฝํ๊ธฐ์ค
- ๋ํ๋ฏผ๊ตญ์ฝ์ ์ธ ํ์ฝ(์์ฝ)๊ท๊ฒฉ์ง
- ๋ฐ์ฅ์๋๋ฐ๋ ๋
- ๋์ฐ๋ณ์ด ์ ๋ฐ๋ฌผ์ง
- ๋์ฐ๋ณ์ด์
- ๋๋์ ํด์ด, ๋ชจ๋ด ํด์ ๋
- ๋์ฉ, ์คํธํ
- ๋
๋ฆฝํ ์์คํ
- ๋
์ผ์ฐ๋ฐฉ ์ํด ํ๊ฐ์
- ๋
์ผ์ฐ๋ฐฉ ์๋น์ ๋ณดํธยท์ํ์์ ์ฒญ
- ๋
์ผ์ฐ๋ฐฉ์ํยท๋๋ฆผยท์๋น์๋ณดํธ๋ถ
- ๋
์ผ์ฐ๋ฐฉ์์ฝํ์๋ฃ๊ธฐ๊ธฐ์ฐ๊ตฌ์
- ๋
์ฑ
- ๋
์ฑ ๊ธฐ์ ์, ๋
์ฑ ๊ฐ์์
- ๋
์ฑ๋๋ ฅํ
- ๋
์ฑ๋ํํ
- ๋
์ฑ๋ฑ๊ฐ๊ฐ
- ๋
์ฑ๋ฑ๊ฐ๊ณ์
- ๋
์ฑ์ฐธ๊ณ ์น
- ๋
์ฝ
- ๋๋จ์์์๊ตญ๊ฐ์ฐํฉ
- ๋๋ฑ์๋ฌผ์์ฝํ
- ๋๋ฌผ ๊ถ๋ฆฌ
- ๋๋ฌผ ๋ชจ๋ธ
- ๋๋ฌผ ๋ณต์ง
- ๋๋ฌผ ์คํ
- ๋๋ฌผ ์ฌ์ก
- ๋๋ฌผ ์ข
- ๋๋ฌผ๋์ฒด์ํ๋ฒ
- ๋๋ฌผ๋์ฒด์ํ๋ฒ๊ตญ์ ํ๋ ฅ
- ๋๋ฌผ์ํ ๋์๋ฐฉ๋ฒ
- ๋๋ฌผ์คํ์ค๋ฆฌ์์ํ, ์คํ๋๋ฌผ์ด์์์ํ
- ๋์์
- ๋ผ์ดํ ์ฌ์ดํด / ์ ํ์๋ช
- ๋๋
ธ ๋ฐ์ด์ค ๊ธฐ๋ฅ์ฑ ์์ฌ
- ๋๋
ธ์์ฒด๋ชจ๋ฐฉ์์ฌ
- ๋ฉ
- ๋ด๋
์, ์๋ํก์ , ๊ตฐ์ฒด๋ด ๋
์
- ๋ด๋ถ๋น๊ณ ์ฅ์ ๋ฌผ์ง
- ๋ด์ ๋
ธ์ถ
- ๋ด์ ๋
ธ์ถ๋
- ๋
ธ๋ ์ดํ๋ฆฌ
- ๋
ธ๋ก๋ฐ์ด๋ฌ์ค
- ๋
ธ์ถ
- ๋
ธ์ถ ๊ธฐ๊ฐ
- ๋
ธ์ถ ๊ธฐ์ ์, ๋
ธ์ถ ๊ฐ์์
- ๋
ธ์ถ ๊ธฐ์ค
- ๋
ธ์ถ ๋๋
- ๋
ธ์ถ ๋น๋
- ๋
ธ์ถ ์๋๋ฆฌ์ค
- ๋
ธ์ถ ์ฉ๋ ์ฌ๊ตฌ์ฑ
- ๋
ธ์ถ ์ฌ๊ฑด
- ๋
ธ์ถ ์กฐ๊ฑด
- ๋
ธ์ถ ์งํ
- ๋
ธ์ถ ์ฒ๋
- ๋
ธ์ถ๊ฒฝ๋ก
- ๋
ธ์ถ ๊ณผ์
- ๋
ธ์ถ ์์ ์ญ
- ๋
ธ์ถ(์ง)์
- ๋
ธ์ถ ํ๊ฐ
- ๋
ธ์ถํ์ฉ๊ธฐ์ค, ๋
ธ์ถํ์ฉ์์ค
- ๋
ผ๋ฌธ ์ชผ๊ฐ๊ธฐ
- ๋๋ - ํจ๊ณผ ๊ณก์
- ๋์ฐ๋ฌผ์ฐ์๊ด๋ฆฌ์ ๋
- ๋์ ๋
ธ์ถ
- ๋์ ๋
ธ์ถํ๊ฐ
- ๋๊ฐ๋ฆผ
- ๋๋ฒ๊น
(์ค๋ฅ์์ )
- ๋์ํธ์คํธ๋ฒ ์คํธ๋กค
- ๋ ๋๋ง
- ๋ก๊ทธ์ ๊ท๋ถํฌ
- ๋กํธ๋ฒํธ, ์ ์กฐ๋ฒํธ
- ๋ฃจํ ์ํ / ์ํ์ํ
- ๋ฃฉ๋ฐฑ
- ๋ฆฌ์คํฌ ์ปค๋ฎค๋์ผ์ด์
/ ์ํด์ ๋ณด๊ตํ
- ๋ฆฌ์คํฌํ์ฉ
- ๋ฆฌ์คํ
๋ฆฌ์
- ๋ฆฌ์คํ
๋ฆฌ์ ๋ชจ๋
ธ์ฌ์ดํ ์ ๋ค์ค
- ๋ฆฌ์คํ
๋ฆฌ์ ์์ค๋
- ๋ฆฌํธ๋์
์์น
- ๋ง์ฑ๋
์ฑ
- ๋ง์ฑ๋
์ฑ์ํ
- ๋ง์ฑ๋
ธ์ถ
- ๋ง์ฑ์ฐธ์กฐ์ฉ๋
- ๋ง๊ฐ
- ๋ง์ถคํ
- ๋ง ํ
์คํธ
- ๋ง๋น์ฑ ํจ๋
- ๋ง๋น์ฑํจ๋
- ๋ง์ฝ
- ๋ง์ฝ์์ํ
- ๋ง์ทจ
- ๋ง๋ผ์นด์ดํธ๊ทธ๋ฆฐ
- ๋งค๋ฅด์ฝ์๋ฅด
- ๋งค์ฒด
- ๋งคH; Forum for the Harmonization ์ด Herbal Medicines
- ๋งน๊ฒํด์ ๊ธฐ๋ฒ
- ๋ฉ๋ผ๋ฏผ
- ๋ฉ์จ์ด
- ๋ฉํธ์์
- ๋ฉํ๊ฒ๋
- ๋ฉํ๋ฝ์ค
- ๋ฉด์ต๋
์ฑ์ํ
- ๋ฉด์ญ
- ๋ฉด์ญ๋
์ฑ
- ๋ฉด์ญ๋
์ฑ์ํ
- ๋ฉด์ญ๋ณด์กฐ์ , ๋ฉด์ญ์ฆ๊ฐ์
- ๋ฉด์ญ์์ฑ
- ๋ฉด์ญํ
- ๋ฉธ๊ท (๋ฒ)
- ๋ฉธ๊ท (๋ฌด๊ท )์
- ๋ชจ๋ํฐ๋ง
- ๋ชจ๋ํฐ๋ง๋ณด๊ณ ์
- ๋ชจ๋ธ
- ๋ชจ๋ธ ๊ฒ์ฆ
- ๋ชจ๋ฒ๋๋ฌผ์ฉ์์ฝํ์ฌ์ฉ๊ท์
- ๋ชจ์์ ํ
- ๋ชจ์ก
- ๋ชฉ์ ์ ์ ํฉํ๊ฒ ๋ฒ์๋ ์คํ๋๋ฌผ
- ๋ชฌํ
์นด๋ฅผ๋ก ์๋ฎฌ๋ ์ด์
- ๋ฌด๊ด์ฉ ์ ์ฑ
, ์ ๋ก ํจ๋ฌ๋ฐ์ค ์ ์ฑ
- ๋ฌด๊ท ๊ตฌ์ญ
- ๋ฌด๊ท ๊ธฐ์ ๋ฐ ์กฐ์๋ฒ
- ๋ฌด๊ท ๋ณด์ฆ ์์คํ
- ๋ฌด๊ท ์ ํ
- ๋ฌด๊ท ์ถฉ์
- ๋ฌด๊ท ๋ณต ์ฐฉ์ฉ ์ ๊ฒฉ์ฑํ๊ฐ
- ๋ฌด๊ท ์ํ
- ๋ฌด๊ท ์ฑ, ๋ฉธ๊ท ๋
- ๋ฌด๊ท ์ฑ ๋ณด์ฆ์์ค
- ๋ฌด์์
- ๋ฌด์์ ํ๋ณธ๊ฒ์ฌ
- ๋ฌด์ ํ ์ฉ๋
- ๋ฌด์ ํ/์์๋
- ๋ฌด์ง์ ๊ณ ํ๋ถ
- ๋ฌด์ฒ์ถ๋๋ฌผ
- ๋ฌดํต ๋ฐฉ๋ฒ
- ๋ฌผ๋ฆฌ์ ๊ฐ์
/ ๊ฐ์ญ
- ๋ฏธ๊ตญ ๊ตญ๋ฆฝ๋
์ฑ์ฐ๊ตฌ์
- ๋ฏธ๊ตญ ๊ตญ๋ฆฝ๋ณด๊ฑด์
- ๋ฏธ๊ตญ ๊ตญ๋ฆฝ์ํ์ฐ๊ตฌ์
- ๋ฏธ๊ตญ ๋๋ฌด์ฑ
- ๋ฏธ๊ตญ ๋ณด๊ฑดํ๊ฒฝ์ฐ๊ตฌ์
- ๋ฏธ๊ตญ ์ํ์์ฝ๊ตญ
- ๋ฏธ๊ตญ ์ํ์์ ๊ฒ์ฌ๊ตญ
- ๋ฏธ๊ตญ ์ํ์์ ․์์ฉ์์์ผํฐ
- ๋ฏธ๊ตญ ์ฌ๋ฃ์ํํํ
- ๋ฏธ๊ตญ ์ฌํฅ๊ตฐ์ธํ
- ๋ฏธ๊ตญ ์ ๊ตญ๋ฒ
- ๋ฏธ๊ตญ ์ด๋ฅ ๋ฐ ์ผ์๋์๋ฌผ ๋ณดํธ๊ตญ
- ๋ฏธ๊ตญ ์ฐ๊ตฌ์ง์ค์ฑ๊ตญ
- ๋ฏธ๊ตญ ์ฐ๋ฐฉ๊ท์ ์ง
- ๋ฏธ๊ตญ ์ข
ํฉ์๋คํธ์ํฌ
- ๋ฏธ๊ตญ ์ง๋ณํต์ ์๋ฐฉ์ผํฐ
- ๋ฏธ๊ตญ ํต์๋ํ๋ถ
- ๋ฏธ๊ตญ ํ๊ฒฝ๋ณดํธ๊ตญ
- ๋ฏธ๊ตญ๊ตญ๋ฆฝ๋
์ฑ์ฐ๊ตฌ์
- ๋ฏธ๊ตญ๊ตญ๋ฆฝ๋ณด๊ฑด์
- ๋ฏธ๊ตญ๊ตญ๋ฆฝ์ํ์ฐ๊ตฌ์
- ๋ฏธ๊ตญ๋๋ฌด๋ถ
- ๋ฏธ๊ตญ๋ณด๊ฑด๋ณต์ง๋ถ
- ๋ฏธ๊ตญ์ํ์์ฝํ์ฒญ
- ๋ฏธ๊ตญ์ํ์์ฝํ์ฒญ๊ฐ์ ๋ฒ
- ๋ฏธ๊ตญ์ํ์์ ๋ฐ์์ฉ์์๊ณต๋์ฐ๊ตฌ์
- ๋ฏธ๊ตญ์ํ์์ ๋ฐ์์ฉ์์์ผํฐ
- ๋ฏธ๊ตญ์ํ์์ ํ๋ํ๋ฒ
- ๋ฏธ๊ตญ์๋ฃ๊ธฐ๊ธฐ๋ฐฉ์ฌ์ ๋ณด๊ฑด์ผํฐ
- ๋ฏธ๊ตญ์ฌ๋ฃ์ํํํ
- ๋ฏธ๊ตญ์๋ฌผํ์ ์ ์ ํ๊ฐ์ผํฐ
- ๋ฏธ๊ตญ์์์์ฝํ์ผํฐ
- ๋ฏธ๊ตญ์ฝ๋ฌผํ๊ฐ์ฐ๊ตฌ์ผํฐ
- ๋ฏธ๊ตญ์ง๋ณํต์ ์๋ฐฉ์ผํฐ
- ๋ฏธ๊ตญํ์คํํ
- ๋ฏธ๊ตญํญ์์ ๋ด์ฑ๊ฐ์์์คํ
- ๋ฏธ๊ตญํ๊ฒฝ๋ณดํธ์
- ๋ฏธ์๋ฌผ ๋ถํ
- ๋ฏธ์๋ฌผํ
- ๋ฏธ์ค์ ADI
- ๋ฏธํต์๋ํ๋ถ
- ๋ฏผ๊ฐ๊ตฐ
- ๋ฏผ๊ฐ๋
- ๋ฏผ๊ฐ๋ ๋ถ์
- ๋ฐ๋ฌ ๋
์ฑ
- ๋ฐ๋ณ๋ฅ
- ๋ฐ์์
- ๋ฐ์์ฑ
- ๋ฐ์์ฑ๋์ฒด์ํ๋ฒ
- ๋ฐ์์ฑ์ํ
- ๋ฐ์ด์ฑ๋ฌผ์ง
- ๋ฐ์ด์ฑ๋ฌผ์ง์ํ
- ๋ฐ์ด์ฑ๋ฌผ์ง์ ๊ฑฐ / ํํ์ด๋ก์
- ๋ฐํ / ๋ด์
- ๋ฐํ (๋ด์) ๊ตฌ์ญ
- ๋ฐ์ค๋ฌ์ค ์ธ๋ ์ฐ์ค
- ๋ฐ์ด๋ฉ ์ถ์ ์น
- ๋ฐ์ด์ค์ ๋ ์๋ฏผ
- ๋ฐ์ด์ค์ ๋์๋ฏผ
- ๋ฐ์ด์ค์นฉ
- ๋ฐํ
๋ฆฌ์๋ฅผ ์ด์ฉํ ๋ณต๊ท๋์ฐ๋ณ์ด์ํ
- ๋ฐ๊ฐ๊ธฐ
- ๋ฐ๋ณต์ฑ
- ๋ฐ๋ณต์ฑ (์ฌํ์ฑ) ์๋ํ์คํธ์ฐจ (๋ณ๋๊ณ์)
- ๋ฐ๋ณต์ฑ (์ฌํ์ฑ) ํ์คํธ์ฐจ
- ๋ฐ๋ณต์ฑ (์ฌํ์ฑ) ํ๊ณ์น
- ๋ฐ๋ณต์ฑ ์กฐ๊ฑด
- ๋ฐ๋ณตํฌ์ฌ๋
์ฑ์ํ
- ๋ฐ์ฌ๊ธฐ๋ฅ๋ฐ๋ฌ์ํ
- ๋ฐ์์น์ฌ๋๋
- ๋ฐ์์น์ฌ์ฉ๋
- ๋ฐ์ ํ
- ๋ฐํ
- ๋ฐฉ๋ฒ๋ก
- ๋ฐฉ๋ถ์
- ๋ฐฉ์ฌ๋ฅ
- ๋ฐฉ์ฌ๋ฅ ๋ฌผ์ง
- ๋ฐฉ์ฌ๋ฅ ์ค์ผ์ํ
- ๋ฐฉ์ฌ๋ฅ ํต์ข
- ๋ฐฉ์ฌ๋ฅ์์ค๋(I-131)/ ๋ฐฉ์ฌ๋ฅ์ธ์(Cs-137)
- ๋ฐฉ์ฌ๋ฅ์ค์ผ
- ๋ฐฉ์ฌ์
- ๋ฐฉ์ฌ์ ์กฐ์ฌ์ํ
- ๋ฐฉ์ฌ์ฑ ์์ฝํ
- ๋ฐฉํ
- ๋ฐฉํ๋ฒฝ
- ๋ฐฐ๊ฒฝ ์์ค
- ๋ฐฐ์ค
- ๋ฐฐ์
- ๋ฐฐ์ ๋ฐฐ์ ๊ธฐ์
- ๋ฐฐ์๊ธฐ
- ๋ฐฐ์ง์ฑ๋ฅ์ํ
- ๋ฐฐ์ง์ถฉ์
- ๋ฐฐ․ํ์๋ฐ์๋
์ฑ์ํ
- ๋ฐฐํฉ
- ๋ฐฑ์
- ๋ฐฑ์ ์ ๋น์์ ํ๊ฐ
- ๋ฐธ๋ฆฌ๋ฐ์ด์
์ค์๊ณํ์
- ๋ฐธ๋ฆฌ๋ฐ์ด์
/ ์ ํจํ
- ๋ฐธ๋ฆฌ๋ฐ์ด์
์ข
ํฉ๊ณํ์
- ๋ฐธ๋ฆฌ๋ฐ์ด์
๋ ๋ฒ์
- ๋ฐธ๋ฆฌ๋ฐ์ด์
๋ ์ํ๋ฒ
- ๋ฒ๊ทธ
- ๋ฒ์
- ๋ฒ์ ๋๋ฆฌ์ธ
- ๋ฒ ํฌ๋
- ๋ฒค์
- ๋ฒค์กฐํผ๋
- ๋ฒค์น๋งํฌ์ฉ๋
- ๋ณ์ด๊ณ์
- ๋ณ์ดํ ํฌ๋ก์ด์ธ ํ ํธ ์ผ์ฝฅ๋ณ
- ๋ณ์
- ๋ณ์กฐ
- ๋ณํํฌ๋ก์ด์ฐ์ธ ์ผ๊ณฑ๋ณ
- ๋ณ์์ฑ
- ๋ณ์์ฑ๋์ฅ๊ท
- ๋ณ์์ฒด
- ๋ณด๊ด์ฉ๊ฒ์ฒด, ๋ณด์กดํ, ์ฐธ๊ณ ํ
- ๋ณด์
- ๋ณด์กด๋ฃ, ๋ณด์กด์
- ๋ณด์กด์
- ๋ณดํด๋ฆฌ์ฆ
- ๋ณต์ฌ์ ๋งฅ
- ๋ณตํฉ๋ฌผ์ง
- ๋ณตํฉ์
- ๋ณธ์ง์ ๋๋ฑ์ฑ
- ๋ถ์์ฉ
- ๋ถ๋ฏธ์์ ๋ฌด์ญํ์
- ๋ถ๋ฅ๊ตฐ
- ๋ถ์ ์๋ฌผํ
- ๋ถ์ฐ๋ถ์
- ๋ถ์๋ฌผ์ง
- ๋ถ์๋ฒ ์ฑ๋ฅ ์ํ
- ๋ถ์๋ฒ์ (๊ฒฝํ์ /๊ด๋ก์ ๊ท์ )
- ๋ถํฌ
- ๋ถํฌ์ ๋ฌด๊ดํ ๋ฐฉ๋ฒ
- ๋ถ์
- ๋ถ์๋ฌผ
- ๋ถ์๋ฌผ ํ๋กํ
- ๋ถํฌํ์ง๋ฐฉ
- ๋ถํ์ฑ์ฑ๋ถ, ์ฒจ๊ฐ์
- ๋ถํ์ค์ฑ
- ๋ถํ์ค์ฑ ๋ถ์
- ๋ถํ์ค์ฑ๊ณ์
- ๋ถํด์ํ
- ๋ธ๋ฃจ์
๋ผ์ฆ
- ๋น๊ฑฐ์ธ ๋ฏธ์ฑ์๋๋ฌผ์ ์ด์ฉํ ๊ฒ์ฆ์ํ
- ๋น๋์นญ ๋น๋ ๋ถํฌ
- ๋น๋ธ๋ฆฌ์ค ํจํ์ฆ
- ๋น์คํ๋A
- ๋น์์์ํ
- ๋น์์์ํ๊ด๋ฆฌ๊ธฐ์ค
- ๋น์ ํ ์ฉ๋ ๋ฐ์
- ๋น์
- ๋น์ญ์น
- ๋น์ ๋ฆฌ๋ฐฉ์ฌ์
- ๋นํ์ค๋ฆฐ
- ์ค๋ํ
- ์ค๋์จ์ด
- ์คํธ๋ ์ค ๋ฐ์
- ์คํ์ด์จ์ด
- ์คํฌ๋ฆฌ๋
- ์ฌ๋กํธ๋์ด๋
- ์๊ฐ ๊ฐ์ค ํ๊ท ๋๋
- ์๊ฐ - ํ๋ ํํ
- ์๋๋ฆฌ์ค ํ๊ฐ
- ์๋ฃ ์ธ์ฆ ์ฐ๊ตฌ
- ์๋ฒํธ
- ์์๊ฐ
- ์์ฅ ๋ฐ๊ตฌ๋ ์กฐ์ฌ๋ฐฉ์
- ์์ ๋ฐ ์๋ฐฉ์กฐ์น
- ์์ ์กฐ์น / ๊ฐ์ ์กฐ์น
- ์ํ๋กํ๋ก์ฌ์
- ์ํ๋ด๋น์/์ฐ๊ตฌ๋ด๋น์
- ์ํ๋์์์๋ณ์ฝ๋
- ์ํ๋์์์ ๋ณต์ง
- ์ํ๋ฌผ์ง
- ์ํ๋ฐฉ๋ฒ
- ์ํ์ฉ ์ ์ฝ
- ์ํ์
- ์ํ์ ๊ธฐ์ ์
- ์ํ์ฅ๋น ๊ธด๊ธ ์ ๊ฒ ยท ๋ณด์
- ์ํ์ฅ๋น ๋ฐธ๋ฆฌ๋ฐ์ด์
- ์ํ์ฅ๋น ์ํ๊ต์
- ์ํ์ฅ๋น ์ด์ ์ ๊ฒฉ์ฑ ํ๊ฐ
- ์ํ์ฅ๋น ์ค๊ณ ์ ๊ฒฉ์ฑ ํ๊ฐ
- ์ํ์ฅ๋น ์ค์น ์ ๊ฒฉ์ฑ ํ๊ฐ
- ์ํ์ฅ๋น ์ฑ๋ฅ ์ ๊ฒฉ์ฑ ํ๊ฐ
- ์ํ์ฅ๋น ์ ๊ธฐ์๋ฐฉ์ ๊ฒ ยท ๋ณด์
- ์ํ์ฝ
- ์์ฉ ํ๋ฅด์์
- ์์ก๊ฐ๊ณตํ
- ์์ด์ฌ์
- ์์ฌ๊ธฐ๋ก๋ฒ
- ์์ค๋
- ์์ค๋
๋ณด๊ณ ๊ด๋ฆฌ์์คํ
- ์์ค๋
์กฐ๊ธฐ๊ฒฝ๋ณด์์คํ
- ์์ค๋
์ง์
- ์ํ ๋งค๊ฐ ๋ณ์์ฒด
- ์ํ๋ฏธ์๋ฌผ์์ธก๋ชจ๋ธ
- ์ํ๋ฐ์ฌ๋ฃ์ ์๊ฒฝ๋ณด์์คํ
- ์ํ์๋ฃ
- ์ํ์์
- ์ํ์์๊ฒ์ฌ๊ธฐ๊ด
- ์ํ์์์ฌ์์์ํ
- ์ํ์ํด์์์ค์ ๊ด๋ฆฌ๊ธฐ์ค
- ์ํ์ด๋ ฅ์ถ์ ๊ด๋ฆฌ
- ์ํ์ญ์ทจ๋
- ์ํ์์ ๊ธฐ์ค์น
- ์ํ์์ ์๋น์์ ๊ณ ์ผํฐ
- ์ํ์์ ์ ์ฑ
์์ํ
- ์ํ์ฒจ๊ฐ๋ฌผ
- ์ํํ
๋ฌ๋์ฑ
- ์ ๊ฒฝ ์๋ฌผํ
- ์ ๊ฒฝ์์ ์
- ์ ๊ฒฝํ
- ์ ๊ณ ๋์์ํ๋ฑ๋ก
- ์ ๋ขฐ๊ตฌ๊ฐ
- ์ ๋ขฐ๋
- ์ ๋ขฐ์ฑ ๋ณด์ฆ๋ถ์
- ์ ๋ขฐํ๊ณ
- ์ ์์ฌ์ํ
- ์ ์์ฌ์ฌ
- ์ ์ง๋์ฌ
- ์ค ์์ฐ๋ / ์๋ / ์๋๋
- ์ค์๊ฐ ์ถํ ์น์ธ ์ํ
- ์คํ์กฐ์ฌ
- ์คํ์กฐ์ฌ ๋ณด๊ณ ์
- ์คํ๊ตฐ
- ์คํ๋๋ฌผ
- ์คํ๋๋ฌผ์ด์์์ํ
- ์คํ๋๋ฌผ์์์ฐ๊ตฌ์
- ์คํ์ค๊ฐ ๋น๊ต ์ํ
- ์คํ์ค๋ด ์ ๋ฐ์ฑ
- ์ฌ๊ฐ์ฑ, ์ค๋์ฑ
- ์ฌ์ฌ๋ฉด์
- ์ธ์ดํผ๋ฉ์ฐ๋ฆฐ
- ์๊ตฌ, ์๊ตฌ์ฌํญ, ํ์์๊ฑด
- ์์ค๋
- ์ฉ๋
- ์ฉ๋ - ๋ฐ์
- ์ฉ๋ - ๋ฐ์ ํ๊ฐ
- ์ฉ๋-๋ฐ์ ํ๊ฐ
- ์ฉ๋ ์กฐ์
- ์ฉ๋ ํจ๊ณผ
- ์ฉ๋ - ํจ๊ณผ ๊ณก์
- ์ฉ๋งคใ๋ถํ์ ๋์กฐ๊ตฐ
- ์ฉ์ถ๊ท๊ฒฉ
- ์ฉ์ถ์ํ
- ์ฐ๋ฐ์ ์ญ์ทจ
- ์ฐ์ ์ ์กฐ ๊ธฐ์ค
- ์ฐ์์์๊ด๋ฆฌ๊ท๋ฒ
- ์ด์ก ๊ธฐ๋ก
- ์ด์ ํ๊ฒฝ / ๊ฐ๋ ํ๊ฒฝ
- ์๋ฃ, ์๋ฃ์ฝํ
- ์๋ฃ / ์ฑ๋ถ
- ์๋ฃ์์ฝํ
- ์๋ฃ์์ฝํ ์ถ๋ฐ๋ฌผ์ง
- ์๋ฃ์์ฝํ / ํ์ฑ์ฑ๋ถ/ ์ ํจ์ฑ๋ถ/ ์ฃผ์ฑ๋ถ
- ์๋ฃ์์ฝํ๋ฑ๋ก์ ๋
- ์๋ฃํ์ฅ
- ์๋ฃํ์ฅ ๋ง์คํฐ ํ์ผ
- ์๋ณธ ์๋ฃ, ๊ธฐ์ด์๋ฃ,์ ๋ฐ์ดํฐ,
- ์์์ฌ
- ์์ฌ๋ฃ
- ์๊ธฐ
- ์๊ธฐ๊ด๋ฆฌ
- ์์์ฑ๋ฅ
- ์์ ๋ฐ ์๋ฌผ์์ ์กฐ์น์ ๊ดํ ํ์
- ์์ ๋ฐ ์๋ฌผ์์ ์กฐ์น์ ๊ดํ ํ์ , SPSํ์
- ์์ ๋ฐ ์๋ฌผ์์์กฐ์น
- ์์์งํ๊ท
- ์์ฝ
- ์์์ฑ๋ฅ
- ์์กฐ
- ์์กฐ, ๋ ์กฐ
- ์ํด ๊ฐ์
- ์ํด ๊ฒํ
- ์ํด ๊ด๋ฆฌ
- ์ํด ๊ด๋ฆฌ ๊ธฐ๊ด
- ์ํด ๊ธฐ์ ์, ์ํด ๊ฐ์์
- ์ํด/์ํด์ฑ/์ํด๋
- ์ํด, ์ํด์ฑ, ์ํ๋, ๋ฆฌ์คํฌ
- ์ํด ํ๊ฐ
- ์ํด ํ๊ฐ ์ ๋ฌธ๊ฐ์์ํ
- ์ํด๊ธฐ์ ์
- ์ํด๋ ๊ฒฐ์
- ์ํด๋ถ์
- ์ํด์์, ์ ํด์ฑ, ์ํ์ฑ
- ์ํด์ฑ ํ๊ฐ
- ์ํด์ํต
- ์ํด์ ๋ณด๊ต๋ฅ
- ์ํด์ง์
- ์ํดํ๊ฐ
- ์ํ์ฑ ๊ฒฐ์
- ์ํ์ฑ ํ์ธ
- ์ ๊ฐ๊ณตํ
- ์ ๊ณ ํ๋ถ
- ์ ๊ธฐ์ฃผ์ํํฉ๋ฌผ
- ์ ๋์์ค์
- ์ ๋ฝ ์์ฝํ ์์ด์ ์
- ์ ๋ฝ์ํ์์ ์ฒญ
- ์ ๋ฝ์์ํ
- ์ ๋ฝ์์ฝํ์ฒญ
- ์ ๋ฝ์ฐํฉ
- ์ ๋ฝ์ฐํฉ ์งํ์์ํ
- ์ ๋ฝํ์คํ์์ํ
- ์ ๋ น์ ์
- ์ ์ ๋
์ฑ
- ์ ์ ๋
์ฑ
- ์ ์ ๋
์ฑ ๋ฐ์๋ฌผ์ง
- ์ ์ ๋
์ฑ์ํ
- ์ ์ ์
- ์ ์ ์ ๊ฒฐ์ ๋ก
- ์ ์ ์ ์ํ
- ์ ์ ์๋ณํ์๋ฌผ์ฒด
- ์ ์ ์์ฌ์กฐํฉ์ํ
- ์ ์ ์์ฌ์กฐํฉ์์ฝํ
- ์ ์ ์์น๋ฃ์
- ์ ์ ์ํ
- ์ ์ ์ ์์ธ๋ก , ์ ์ ์์ธ์ฃผ์
- ์ ์ ์ฒด
- ์ ์ ์ฒดํ
- ์ ์ ํ
- ์ ์ถ ํคํธ
- ์ ํจ์ฉ๋
- ์ ํจ์ฑ๋ถ, ์ฃผ์ฑ๋ถ
- ์ ํจ์ฑ์ํ
- ์ ํต๊ธฐํ, ํ์ง์ ์ง๊ธฐํ
- ์ ํด๋ฌผ์ง์ ํ๊ณ ์์ค / ์กฐ์น์์ค
- ์ ํด์ํฅ
- ์ ํด์ํฅ์ ๋ฐ์ธ์
- ์ ํด์ค์ผ๋ฌผ์ง
- ์ ํฌ์ค์ผ์ด ์๋ฃ๊ธฐ 7l
- ์์ฉ์ ๋
ธ์ถ
- ์์ ๋ฐฉ์
- ์์ฑ๋์กฐ๊ตฐ
- ์๋ขฐ์-์ํ์
- ์๋ขฐ์, ์์์ํ์๋ขฐ์
- ์๋ฃ๊ธฐ๊ด ํ๊ฐ์์ํ, JCI
- ์๋ฃ๊ธฐ๊ธฐ ์์์ ์กฐํํ์
- ์๋ฃ๊ธฐ๊ธฐ ์์ ๋ฒ
- ์๋ฃ๊ธฐ๊ธฐ์์ํ
- ์๋ฃ๊ธฐ๊ธฐ์์์ํ์คํํ์
- ์์ฌ๋๋ ์ ํด๋ฐ์
- ์์ฝํ
- ์์ฝํ ์ํ๊ฒ์
- ์์ฝํ ์ ์ต์ฑ-์ํด์ฑ ๊ท ํ ํ๊ฐ
- ์์ฝํ / ์ ์ฝํ
- ์์ฝํ ์ ์กฐ ๋ฐ ํ์ง๊ด๋ฆฌ ๊ธฐ์ค
- ์์ฝํ ํ๊ฐ์ ์ฒญ
- ์์ฝํ๊ตญ์ ๊ณตํต๊ธฐ์ ๋ฌธ์
- ์์ฝํ๊ตญ์ ์กฐํํ์
- ์์ฝํ์ ์ ์กฐ, ๊ฐ๊ณต, ํฌ์ฅ, ๋๋ ๋ณด๊ด
- ์ด๋ก ์๋, ์ด๋ก ์์ฐ๋
- ์ด๋ก ์์จ์ ๋ฐฑ๋ถ์จ
- ์ด๋ก ์ ์ผ์ผ์ต๋์ญ์ทจ๋
- ์ด๋ณ๋ฅ
- ์ด๋ด ๋ถํฌ
- ์ด์๋
์ฑ๋ถ์ ์ํ
- ์ด์์น
- ์ด์ข
์ด์
- ์ด์ข
์ด์์ฌ
- ์ด์ค ์ธ์ฆ
- ์ดํผ์
- ์ดํด ๊ด๊ณ์
- ์ดํด ์์ถฉ
- ์ดํ์
- ์ธ๊ฐ๋์์ฐ๊ตฌ
- ์ธ๊ณต ์ฅ๊ธฐ
- ์ธ๊ณต ์ง๋ฅ
- ์ธ๊ตฌํต๊ณํ
- ์ธ์
- ์ธ์๊ณตํต ๋ณ์๊ท
- ์ธ์๊ณตํต ์ง๋ณ
- ์ธ์๊ณตํต์ ์ผ๋ณ
- ์ธ์ฆํ์ค๋ฌผ์ง
- ์ธ์ฒด ๋
ธ์ถ ํ๊ฐ
- ์ธ์ฒด๋
ธ์ถ์์ ๊ธฐ์ค
- ์ธ์ฒด๋
ธ์ถํ์ฉ๋/์ธ์ฒด๋
ธ์ถ์์ ๊ธฐ์ค
- ์ธ์ฒด๋ชจ๋ํฐ๋ง
- ์ธ์ฒด์์๋๋, ์ธ์ฒด์์์ฉ๋
- ์ธ์ฒด์กฐ์ง
- ์ธํฐํ์ด์ค
- ์ผ๋ฐ ์ง๋จ
- ์ผ๋ฐ๋
์ฑ
- ์ผ๋ฐ๋
์ฑ์ํ
- ์ผ๋ฐ์์ฝํ
- ์ผ๋ฐ์ฝ๋ฆฌ์ํ
- ์ผ๋ฐ์ ์ผ๋ก ์์ ํ ๋ฌผ์ง
- ์ผ๋ณธํ์๋
ธ๋์ฑ
- ์ผ์์ ์ธ ํต์ฆ
- ์ผ์ธ๋น ์ญ์ทจ๋
- ์ผ์ผ์ญ์ถ|ํ๊ณ๋
- ์ผ์ผ์ญ์ทจํ๊ณ๋, ์ผ์ผ๋ด์ฉ์ญ์ทจ๋
- ์ผ์ผ์ญ์ทจํ์ฉ๋
- ์ผ์ผ์ต์ ํ์ฉ๋
- ์ผ์ผ์ถ์ ์ญ์ทจ๋
- ์ผ์ผ์ถ์ ์ต๋์ญ์ทจ๋
- ์ผํ ๋ถ๋
- ์๊ณ๊ฐ
- ์์์ํ
- ์์์ํ ๊ณํ์
- ์์์ํ ๋์ ์คํ์กฐ์ฌ
- ์์์ํ ๋ฐ ๋์์๋ณดํธํ๋ก๊ทธ๋จ
- ์์์ํ ์ ์ฒญ
- ์์์ํ๊ด๋ฆฌ๊ธฐ์ค
- ์์์ํ๋์์
- ์์์ํ๋์์, ์ฐ๊ตฌ๋์์, ์ํ๋์์
- ์์์ํ์ฉ ์๋ฃ๊ธฐ๊ธฐ
- ์์์ํ์ฉ ์๋ฃ๊ธฐ๊ธฐ์ ์น๋ฃ๋ชฉ์ ์ฌ์ฉ
- ์์์ํ์ฉ ์์ฝํ
- ์์์ํ์ฉ ์ ํ
- ์์์ํ์ ์๋ฃ์ง
- ์๊ถ๋น๋๋ฐ์์ํ๋ฒ
- ์๊ถ์์ Glutathione Peroxidase ์ํ๋ฒ
- ์๊ธฐ ๋ฐํ ๊ตฌ์ญ
- ์๊ธฐ์๊ด
- ์๋ํ ์์คํ
- ์๋ฃ์ ์ถ์์ฝํ
- ์์ฐ๋
์
- ์์ธ์ A ์ฐจ๋จ๋ฑ๊ธ
- ์์
์ํ
- ์๋ฅ๊ท๊ฒฉ
- ์๋ฅ๋๋ฌผ์ฉ์์ฝํ ์ต๋ํ์ฉ๊ธฐ์ค
- ์๋ฅ๋์ฝ
- ์๋ฅ์ฑ ์ ๊ธฐ์ค์ผ๋ฌผ์ง
- ์๋ฅ์ฑ์ ๊ธฐ์ค์ผ๋ฌผ์ง
- ์์ฌ ์ฝ๋ฌผ
- ์ ์ฌ ๋
ธ์ถ(์)
- ์ ์ฌ ์ฉ๋
- ์ ์ฌ์ ๋
ธ์ถ
- ์ ์ ์๋ฅํ์ฉ๊ธฐ์ค
- ์ ์ ์๊ฐ์ต๋์ญ์ทจํ๊ณ๋, ์ ์ ๋ด์ฉ์๊ฐ๋
ธ์ถ๋
- ์ ์ ์ผ์ผ ์ญ์ทจํ์ฉ๋
- ์ ์ ์ฃผ๊ฐ์ญ์ทจํ๊ณ๋
- ์ ์ ์ฃผ๊ฐ์ญ์ทจํ๊ณ๋, ์ ์ ๋ด์ฉ์ฃผ๊ฐ๋
ธ์ถ๋
- ์ ์ ์ต๋๋ด์ฉ(่ๅฎน)์ผ์ผ๋
ธ์ถ๋
- ์ฅ๊ด์ถํ์ฑ ๋์ฅ๊ท
- ์ฅ๊ธฐ ๋ฐฐ์
- ์ฅ๊ธฐ ๋ฐฐ์ ๊ธฐ์
- ์ฅ๋ด์ธ๊ท ๊ณผ
- ์ฅ๋ฒฝ / ๋ฐฐ๋ฆฌ์ด
- ์ฅ์ฉ์ฑ์ ์
- ์ฅ์ผ ๋น๋ธ๋ฆฌ์ค
- ์ฌ ์ง์
์ฉ๋ ์์ค
- ์ฌ๊ฐ๊ณต
- ์ฌ๋ฐธ๋ฆฌ๋ฐ์ด์
- ์ฌ์ํ๋ ์ง
- ์ฌ์ฌ์ฌ
- ์ฌ์๊ธฐ๊ฐ
- ์ฌ์์
, ์ฌ์ฒ๋ฆฌ
- ์ฌ์ง์ํ
- ์ฌํ์ฑ / ์คํ์ค๊ฐ ์ ๋ฐ์ฑ
- ์ฌํ์ฑ ์กฐ๊ฑด
- ์ฌ๋ํ์ฒญ์๋ถ๋ฏผ
- ์ฌ๋ฃ์ฒจ๊ฐ๋ฌผ
- ์ฌ์ํ ์นจํด
- ์ฌ์นด์ํค๊ท
- ์ฐ๋์กฐ์ ์
- ์ฐํ๋ฐฉ์ง์
- ์ด๊ท ์
- ์ด๋ชจ๋ฌ๋ผ
- ์ด์(๋ฌผ)์
- ์ ๋ถํด
- ์๊ฒ
- ์๋ฆฌํ
- ์๋ฆฌํ์ ์ฝ๋ํ๋ชจ๋ธ
- ์๋ช
์ค๋ฆฌ
- ์๋ช
์งํ, ํ๋ ฅ์งํ
- ์๋ฌผ ๋ฌผ๋ฆฌํ
- ์๋ฌผ ์ธ์ / ์๋ฌผํ์ ์ธ์
- ์๋ฌผ๋์ถ๊ณ์
- ์๋ฌผ์์ฝํ
- ์๋ฌผ์์ฝํํ์คํ์ ๋ฌธ๊ฐ์์ํ
- ์๋ฌผ์ ๋๋ ์ดํฐ
- ์๋ฌผ์ ๋ณดํ
- ์๋ฌผ์งํ
- ์๋ฌผํ์ ๋งค์ฒด
- ์๋ฌผํ์ ๋ชจ๋ํฐ๋ง
- ์๋ฌผํ์ ์ฉ๋๋ฐ์ ๋ชจ๋ธ
- ์๋ฌผํ์ ์ ์ฉ์ฑ์๋ฃ
- ์๋ฌผํ์ ์ด์ฉ๊ฐ๋ฅ์ฑ/ ์์ฒด์ด์ฉ๋ฅ
- ์๋ฌผํ์ ์ญ์ทจ
- ์๋ฌผ(ํ์ ) ์งํ
- ์๋ฌผํ์ ํ์ง์
- ์๋ฌผํ์ ๋๋ฑ์ฑ์ํ
- ์์ ๋
์ฑ
- ์์๋
์ฑ
- ์์๋ฐ์๋
์ฑ์ํ
- ์์․๋ฐ์๋
์ฑ์ํ
- ์์ฐ
- ์์๋ฐ์๋
์ฑ์ํ
- ์์ฝ
- ์์ฝ์ ์
- ์์กด ์์
- ์์กด๋ ฅ
- ์์ฒด๋ด
- ์์ฒด๋ด ๋ณํ
- ์์ฒด์ด์ฉ๋ฅ
- ์์ฒด์ธ
- ์์ฒด์งํ
- ์์ฒด์ถ์
- ์ํ๋
์ฑํ
- ์ํํ
- ์๊ด๊ณ์
- ์๊ด๊ด๊ณ
- ์์นํจ๊ณผ
- ์์ฉ ์ํํธ์จ์ด
- ์์ ๋
ธ์ถ (์ฉ๋) ์ถ์ ์น
- ์ํ
- ์ํฅ์ ์ ๊ทผ๋ฐฉ์
- ์ํธ์ธ์ ํ์
- ์ํธ์์ฉ
- ์๋ช
๋ชฉ๋ก
- ์๋ฐฉ์ฑ์ ์
- ์๋ฒ ์ผ๋ฐ์ค
- ์ ํ์ฑ
- ์ ํ์ ์ฆ๊ท ๋ฐฐ์
- ์ ํ ๋ชจํ
- ์ค์ก
- ์ฌ์
- ์ฌ์ ๋ฅผ ๋ฐฉ์ถํ์ง ์๋ ํํฐ
- ์ญ์ทจ
- ์ญ์ทจ๋
- ์ญ์ทจ๋ฅ
- ์ฑ๊ณผ ์งํ
- ์ฑ๋ฅ์ ๊ฒฉ์ฑํ๊ฐ
- ์ธ๊ณ๋๋ฌผ๋ณด๊ฑด๊ธฐ๊ตฌ
- ์ธ๊ณ๋ณด๊ฑด๊ธฐ๊ตฌ
- ์ธ๊ณ๋ณด๊ฑด๊ธฐ๊ตฌ-์ํํ์์ง์ญ์ฌ๋ฌด์ฒ
- ์ธ๊ณ๋ณด๊ฑด๊ธฐ๊ตฌ์ํํ์์ง์ญํ์ฝ๊ท๊ฒฉ๊ตญ์ ์กฐํํ์์ฒด
- ์ธ๊ณ๋ณด๊ฑด๊ธฐ๊ตฌํ๋ ฅ์ผํฐ
- ์ธ๊ท
- ์ธ๊ทน๋ฑํ๋ฏธ๊ฒฝ
- ์ธ์ฒ ๋ฐธ๋ฆฌ๋ฐ์ด์
- ์ธํฌ
- ์ธํฌ ๋ถํ
- ์ธํฌ๊ฐ์ผ์ฉ๋
- ์ธํฌ๋
์ฑ์ํ
- ์ธํฌ์ ์ ํ์ ํ๊ฐ
- ์ธํฌ์ฃผ
- ์ธํฌ์ฆ์์ํ
- ์ธํฌ์น๋ฃ์
- ์
๋ ๋
- ์
ฐ์ด์จ์ด
- ์ ํด๋ฉด์๋์ฆ
- ์๋
- ์๋
์ / ์๋
์ฝ
- ์๋น์๋ณดํธ์ ์ ์์ค
- ์์ค ์ฝ๋
- ์์๋ฅผ ์ํ ์ต์ ์ ์ ์ฝ์คํ๋ฒ
- ์ํฌ์
- ์ํด๋ฉด์๋์ฆ
- ์ํต์ํ
- ์๋ผ๋
- ์๊ฐ ํฌ์ธํธ(์ ) ๋
ธ์ถ
- ์๊ฐ๋์ ๋
ธ์ถ
- ์๊ฐํ๊ท ๋
ธ์ถ
- ์๋ ์ํ
- ์๋์ํ
- ์๋ ๊ฒฝํผ ์๋ํ๋ฝ์์ค ์ํ
- ์์ฉ์ฒด
- ์์ฉ์ฒด ์ง๋จ
- ์์จ ๊ด๋ฆฌ ๊ธฐ์ค
- ์์์ฌ
- ์์
์ํ ์๋ฅํ์ฉ๊ธฐ์ค
- ์์ปท ์ฑ์ ๋น๋ ๋ฐ์ ์ํ
- ์ํ๋ฅ ๋ฐ ์ด๊ธฐ๋ฐฐ ๋ฐ์์ํ
- ์ํ๋ชจ๋ธ
- ์ํ์ ๋ชจ๋ธ
- ์ํ์
- ์จํจ๋
- ์๋๋ผ
- ์๋๋ฆฐ / ๋์๋๋ฆฐ
- ์๋ ๋ฅด๊ธฐ ๋ฐ์
- ์๋ฃจ๋ฏธ๋
- ์์ฝ์ฌ
- ์ํฌํ๋
- ์๊ธ์ฑ๋
์ฑ, ์๋ง์ฑ๋
์ฑ
- ์๊ธ์ฑ๋
์ฑ์ํ
- ์๋ํ๋ฝ์์ค ์ผํฌ ๋ฐ์์ํ
- ์๋ง์ฑ ๋
์ฑ
- ์๋ง์ฑ ๋
ธ์ถ
- ์๋ฏธํธ๋ผ์ฆ
- ์์์์ฑ ํ๋
- ์์ด์๋ ์ดํฐ
- ์์ธํธ์๋ฐํ๋
- ์ํฌ
- ์ํฌ๋ฆด๋ก๋ํธ๋ฆด-๋ถํ๋์-์คํฐ๋ ์์ง
- ์ํฌ๋ฆด์๋ง์ด๋
- ์ํ๋ผํก์
- ์์ ๊ณ์
- ์์ ์ฑ์ฝ๋ฆฌ์ํ
- ์์ ์ฑํ๊ฐ
- ์์ ์ญ
- ์์ ๋ง์๊ทน์ํ
- ์์ ์ํ ๋
ธ์ถ
- ์์ ์ฑ์ํ
- (์์ปท)์ฑ์ฑ์์ํ๋ฒ
- ์ํผ์ค๋ฆฐ
- ์ํธํ
- ์ ๋์จ์ด
- ์กํ์ฑ ๊ฐ์ค
- ์ฝ๋ํ ๋ชจ๋ธ
- ์ฝ๋ํ, ์ฝ๋ฌผ๋ํํ
- ์ฝ๋ ฅํ, ์ฝ๋ฌผ๋๋ ฅํ
- ์ฝ๋ฆฌ(ํ)์ํ
- ์ฝ๋ฌผ ๊ธธํญ์์ฉ
- ์ฝ๋ฌผ ๋
์ฑ
- ์ฝ๋ฌผ ๋๋ฐ์์น ํจ๊ณผ
- ์ฝ๋ฌผ ๋ณ์ฉ
- ์ฝ๋ฌผ ์ํธ์์ฉ
- ์ฝ๋ฌผ ์น๋ฃ
- ์ฝ๋ฌผ ํ๊ฐ
- ์ฝ๋ฌผ๊ฐ์
- ์ฝ๋ฌผ๋ํํ์ ์ํ
- ์ฝ๋ฌผ์ ์ ์ ๋ณด
- ์ฝ์ ์ ํญ์ฑ
- ์ฝํ ๊ฐ๋ฐ
- ์์ฑ๋์กฐ๊ตฐ
- ์ํด๊ฐ์
- ์ด๋ฆฐ์ด๊ธ์๊ด๋ฆฌ์ง์์ผํฐ
- ์ด๋ฆฐ์ด๊ธฐํธ๊ธฐํ
- ์ด๋ฆฐ์ด์์ํ์์ ์ง์
- ์ด๋ฆฐ์ด์ํ์์ ๋ณดํธ๊ตฌ์ญ
- ์ด์ฅฌ๋ฒํธ
- ์ดํ๋ฆฌ์ผ์ด์
- ์ดํ๋ฆฌ์ผ์ด์
-ํน์ ์ฉ๋์ ์ํํธ์จ์ด
- ์ผํ๊ด์ ๋๊ฒจ
- ์๋ฆฌ์ค๋ก๋ง์ด์
- ์์คํธ๋ก๊ฒ ์์ฉ์ฒด ๊ฒฐํฉ์ํ๋ฒ
- ์์ดํจ๋
- ์์ด๋กํฌ / ์ ์ค
- ์ํธ์นด๋ฐ๋ฉ์ดํธ
- ์์ค์
- ์๋์คํ
- ์๋ํฌ์๋ ์ปค๋ฎค๋์ผ์ด์
/ ๋จ๋๋จ ์ปค๋ฎค๋์ผ์ด์
- ์ฌ์๋์
- ์ฌ์๋์ ์์ค๋
- ์ญ๊ฐ
- ์ญ๋ดํฌ์ฐฐ์ ๊ฒฝ์ ๋๋ฐ์ํ์
- ์ญ์น
- ์ญํ
- ์ญํ(์ )์กฐ์ฌ
- ์ฐ๊ด์ฃผ์ ์ด, ์ ์์ด
- ์ฐ๊ตฌ ๊ฐ์ ๋ฐฉ๋ฌธ
- ์ฐ๊ตฌ ์ค์๊ธฐ๊ด ๋ฐฉ๋ฌธ
- ์ฐ๊ตฌ ์ค์๊ธฐ๊ด ํ๊ฒฌ ๋ชฉ๋ก/์ผ์ง
- ์ฐ๊ตฌ๊ฐํธ์ฌ, ์์์ฐ๊ตฌ์ฝ๋๋ค์ดํฐ
- ์ฐ๊ตฌ๋์์, ์ํ๋์์
- ์ฐ๊ตฌ๋์์/์ํ๋์์ ๋ฑ๋ก ์ผ์ง
- ์ฐ๊ตฌ๋์์/์ํ๋์์ ์ผ์ง
- ์ฐ๊ตฌ๋์์์์ ๊ตญ
- ์ฐ๊ตฌ์ ์ฃผ๋ ์์์ํ
- ์ฐ๋ฐฉ๊ฑฐ๋์์ํ
- ์ฐ์ ์๊ฐ ๋ชจ๋ธ
- ์ผ์์ฒด ์ด์์ํ
- ์ผํ๋น๋
- ์๊ตญ ๊ตญ๋ฆฝ์๋ฌผํ์คํต์ ์ฐ๊ตฌ์
- ์๊ตญ ์ํ๊ธฐ์ค์ฒญ
- ์๊ตญ ํ๊ฒฝ์ํ ๋์ด๋ถ
- ์์๊ฐ์กฐํ์
- ์์์ฑ๋ถํ์
- ์์๋ณด์ถฉ์ฉ์ํ
- ์๋ฐฉ ์กฐ์น
- ์๋น์ฌ์ฌ
- ์์ํ์ง ๋ชปํ ์ด์์๋ฃ๊ธฐ๊ธฐ๋ฐ์
- ์์ํ์ง ๋ชปํ ์ด์์ฝ๋ฌผ๋ฐ์
- ์์ธก๋ชจ๋ธ
- ์ค๋ ์ง II
- ์ค๋ฒํฌ ๋ฉธ๊ท ๊ณต์
- ์ค์ผ
- ์ค์ผ๋ฌผ์ง
- ์ค์ผ์ ๊ฑฐ
- ์ค์ฐจ
- ์คํฌ๋ผํก์ A
- ์ฅ์ํ
ํธ๋ผ์ฌ์ดํด๋ฆฐ
- ์จํ๋๋ฌผ/์ ์จ๋๋ฌผ
- ์๊ฑด์ฑ (๋๊ฐ๋)
- ์์ ์์ฝํ
- ์์ ์์ฝํ, ์ ์ ,์ฝ์
- ์์ ํ, ์ต์ข
์ ํ
- ์ธ์ํธ
- ์ 1์ ์์์ํ
- ์ 2์ ์์์ํ
- ์ 3์ ์์์ํ
- ์ ๊ท ๊ธ ํํฐ
- ์ ๋๋ ๋
ผ
- ์ ๋ค๋ฆญ ์์ฝํ
- ์ ๋ค๋ฆญ์์ฝํ
- ์ ๋ก ๋ฆฌ์คํฌ
- ์ ์๋ฆฌ์
- ์ ์ฝ ์์ด์๋ ์ดํฐ
- ์ ์ฝ ํ์ง ์์คํ
- ์ ์กฐ
- ์ ์กฐ๊ธฐ๋ก์, ์ ์กฐ๋จ์ ๊ธฐ๋ก(์)
- ์ ์กฐ๋จ์, ๋กํธ
- ์ ์กฐ๋จ์ / ๋ฐฐ์น / ๋กํธ
- ์ ์กฐ๋ฒํธ / ๋ฐฐ์น ๋ฒํธ/ ๋กํธ ๋ฒํธ
- ์ ์กฐ์ฉ์ / ์ฉ๋งค
- ์ ์กฐ์
, ์ ์กฐ์
์
- ์ ์กฐ,ํ๋งค ์น์ธ
- ์ ํ ๊ตฌํ
- ์ ํ ์๋ช
- ์ ํ ํน์ฑ ๋ถ์
- ์ ํํ์ค์
- ์ ํํจ์
- ์ 1์ ์
- ์ ํด ๋๋ 50
- ์ ์ฉ๊ฐ๋ฅ์ฑ
- ์ ์ ๋๋ฌผ ๋ชจ๋ธ
- ์ ํฉ๊ธฐ์ค / ํ์ฉ๊ธฐ์ค์น
- ์ ๋ฌ ์ฉ๋
- ์ ๋ฆฌ๋ฐฉ์ฌ์
- ์ ์
- ์ ์ ๊ฐ์ผ
- ์ ์ ์ฉ๋
- ์ ์ผ์ฑํด๋ฉด์๋์ฆ
- ์ ํฅ์ ๊ฒ์ฆ / ์์ธก์ ๋ฐธ๋ฆฌ๋ฐ์ด์
- ์ ์ฐจ (์)
- ์ ์ถ์
- ์ ์ด (์ง)์ ๋
ธ์ถ
- ์ ์ด๋ฅ
- ์ ๊ท ๋ถํฌ
- ์ ๊ท์ฌ์ฌ, ์ ์์ฌ์ฌ
- ์ ๊ท ์์ฉ
- ์ ๋ ๊ด๋ฆฌ
- ์ ๋ ํ๊ณ
- ์ ๋์ ๊ตฌ์กฐ ํ์ฑ์๊ด๊ด๊ณ
- ์ ๋์ ์ํด ํ๊ฐ
- ์ ๋ฐ๋, ์ ๋ฐ์ฑ
- ์ ๋ณด์์ ๋ฒ
- ์ ์ฐ, ๋์กฐ, ์กฐ์ฌ
- ์ ์์ ํด ์ํ
- ์ ์ฑ์ ๋ฐ์ดํฐ
- ์ ์ฑ์ ์ํด ํ๊ฐ
- ์ ํ๋, ์ ํ์ฑ
- ์กฐ๋ฅ์ธํ๋ฃจ์์
- ์กฐ์ ๋ณ์
- ์กฐ์ง
- ์กฐ์ง ๋ฐฐ์
- ์กฐ์ง ๋ฐฐ์ ๊ธฐ์
- ์กฐ์ง๊ณตํ์ ์
- ์ข์ ์ฐ๊ตฌ์ํ
- ์ข
๋จ์ฐ๊ตฌ
- ์ข
๋ง์
- ์ฃผ์
- ์ค์ธํฌ ๋ถํ
- ์ค๊ธฐ์ธํฌ
- ์ค๊ฐ ๋
ธ์ถ
- ์ค๊ฐ ์์์ํ ๊ฒฐ๊ณผ๋ณด๊ณ ์
- ์ค๊ฐ๋ฌผ์ง, ๊ณต์ ์ค ๋ฐ์๋ฌผ์ง
- ์ค๊ฐ์ฒด
- ์ค๋ํ ์ ํด์ฌ๋ /์ฝ๋ฌผ์ ํด๋ฐ์
- ์ค๋
- ์ค๋ณต ์ถํ
- ์ค์ ๊ตฌ์ญ
- ์ค์ ์กฐ์ (์์
)
- ์ค์ ์ง์ญ
- ์ค์ ํ๋ฉด
- ์ค์ ํ์ง ํน์ฑ
- ์ค์๊ฐ
- ์ค์ถ์ ๊ฒฝ๊ณ ์ผ๋ฐ์ฝ๋ฆฌ์ํ
- ์คํฉํจ์ ์ฐ์ ๋ฐ์๋ฒ
- ์คํฉํจ์์ฐ์๋ฐ์
- ์ฆ๊ฑฐ์ ๊ฐ์ค์น
- ์ฆ๋ฅ์
- ์ฆ๋ฐ์๋ฅ๋ฌผ
- ์ฆ์
- ์ฆ์์ผ์ง
- ์ฆ์ ์
- ์ง์ฐํจ๊ณผ
- ์ง์ฐํ๊ณผ๋ฏผ๋ฐ์์ํ
- ์ง์ ์ฑ
- ์ง์
์ ๋
ธ์ถ(ํ์ฉ) ํ๊ณ
- ์ง์ ๊ฒ๊ฒฝ๋ฒ
- ์ง๋จ
- ์ง๋
- ์ง๋ฃ ์์ํ
- ์งํต์
- ์ง๋ณ๋ฐ์ ์ํ ๊ฐ์ ๊ธฐ๋ฅ
- ์งํ๋ชจ๋ธ๋๋ฌผ
- ์ง๋จ
- ์งํฉ์ ๊ฐ๋ค์ด ๊ฐ์ง๋ ์ค์ํ ํน์ง์ ์์ฝํ๊ฑฐ๋ ํน์ ๋ํ์ํจ ๊ฒ์ด๋ค.
- ์งํ
- ์ฐฉ์์ ๋ฐฐ์๋ฐฐ์๋ฒ
- ์ฐธ๊ฐ
- ์ฐธ๊ณ ๋
ธ์ถ๋
- ์ฐธ์ฌ์ค๋จ/์ฒ ํ
- ์ฑ
์ ์๋ ์น๋ฃ์ ์ฐ๊ตฌ๋ฅผ ์ํ ์๋ฏผ
- ์ฒ์ฐ์ฐฉํฅ๋ฃ
- ์ฒ์ฐ์ฒจ๊ฐ๋ฌผ
- ์ฒ์ถ๋๋ฌผ
- ์ฒจ๋จ ์ ์ ์๋ช
- ์ฒญ์ / ๋ฐํ (๋ด์) ๊ตฌ์ญ
- ์ฒญ์ ๊ตฌ์ญ
- ์ฒญ์ ๋ฑ๊ธ
- ์ฒญ์ ์ค
- ์ฒญ์ ์ง์ญ
- ์ฒด๋ด ์ถ์ (๋ถํ)๋
- ์ฒด์ค
- ์ด ๋
ธ์ถ
- ์ด ์์ด์กฐ์ฌ
- ์ด ์ ํจ๋ฑ๊ฐ ์ฉ๋
- ์ด ์ธ์ฒด๋
ธ์ถ๋
- ์ด ์ก์ฒด์ญ์ทจ(๋)
- ์ด๊ธฐ์ํด๊ด๋ฆฌํ๋
- ์ด๋น(์ ๋ฌผ)์ ์
- ์ด์ง์
- ์ต๊ณ ํ์ค๋๋
- ์ต๊ณ ํ์ค๋๋ ๋๋ฌ์๊ฐ
- ์ต๊ธฐํ์ฑ
- ์ต๊ธฐํ์ฑ์ํ
- ์ต๋ ๊ธฐ์ค
- ์ต๋ ๋ด์ฑ์ฉ๋
- ์ต๋ ๋
ธ์ถ๋ฒ์
- ์ต๋ ๋
ธ์ถ์, ์ต๊ณ ๋
ธ์ถ์
- ์ต๋ ๋
ธ์ถํ๊ณ
- ์ต๋๋ฌด๋
์ฑ์ฉ๋
- ์ต๋๋ฌด์์ฉ๋
- ์ต๋์ฉ๋
- ์ต๋์๋ฅํ์ฉ๊ธฐ์ค
- ์ต๋น์
- ์ต์์ํด๊ธฐ์ค
- ์ต์์ ํด์ฉ๋
- ์ต์์ง์ํ์ฆ์ํํ๋
- ์ต์ํ๋ฐ๋
- ์ต์
์ ๊ฒฝ์ฐ
- ์ต์ข
๋ณด๊ณ ์, ๊ฒฐ๊ณผ๋ณด๊ณ ์
- ์ตํํต์ฒฉ ๊ฒ์
- ์ตํ๊ตญ
- ์ตํ๊ตญ ๋์ฐ
- ์ถ๋ฐ ๋ฌผ์ง
- ์ถํ ์น์ธ ์ฑ
์์
- ์ถ๊ฐ์ ์ข
- ์ถ์ ๊ด๋ฆฌ๋์ ์๋ฃ๊ธฐ๊ธฐ
- ์ถ์ ์กฐ์ฌ
- ์ถ์ ๋
ธ์ถ์ฉ๋
- ์ถ์ฐ๋ฌผ์์์ฌ์์์ํ
- ์ถฉ๋ถํ ์ค๋ช
์ ๊ทผ๊ฑฐํ ๋์, ๋์์ ๋์
- ์ทจ์ฝํ ํ๊ฒฝ์ ์๋ ์ํ๋์์
- ์ธก์ ๋
- ์ธก์ ๋ฐฉ๋ฒ
- ์ธก์ ๋ถํ๋
- ์ธก์ ์๊ธ์ฑ
- ์ธก์ ์ ์ฐจ
- ์น๋ฃ๊ณ์
- ์น์ฌ๋
- ์นจ์ถ์ฉ๋งค
- ์นด๋๋ฎด
- ์บ๋๋ค ๋ณด๊ฑด๋ถ
- ์บ๋๋ค ์ํ๊ฒ์ฌ์ฒญ
- ์บ๋ฆฌ์ค๋ฒ
- ์บ ํ๋ก๋ฐํฐ๊ท
- ์ปดํ๋ผ์ด์ธ์ค ๋ชจ๋ํฐ๋ง
- ์ฝ๋ก๋ ํ์ฑ ๋จ์
- ์ฝ๋ก๋ํ์ฑ์ํ
- ์ฝ๋ฐํธ
- ์ฝํธํธ
- ํธ๋์ค์ง๋ฐฉ
- ํธ๋ฆฌํด๋ก๋ก์ํธ๋
- ํน์ด๋, ํน์ด์ฑ
- ํน์ฑ์กฐ์ฌ์๋ น
- ํน์์ฉ๋์ํ
- ํน์ ๋ณ์์ฒด๋ถ์ฌ์คํ๋๋ฌผ
- ํน์ ์ํ๋ฌผ์ง
- ํน์ ์ํ๋ถ์
- ํ๋ผ๋ฉํธ๋ฆญ๋ฆด๋ฆฌ์ค, ๋งค๊ฐ๋ณ์ ์ถํ์น์ธ
- ํํค๋ฆฐ
- ํจ์นญ
- ํธํฅ์ฑ / ๋ฐ์ด์ด์ค
- ํ๊ท ๊ธฐ๋์๋ช
- ํฌ๋ฅด๋ง๋ฆฐ
- ํฌ์คํํ์
- ํฌ์ ์ด๊ท ๊ณต์
- ํฌ์ ์ด๊ท ์
- ํฌ์ฅ
- ํฌ์ฅ์์ฌ
- ํฌ์งํฐ๋ธ๋ฆฌ์คํธ์์คํ
- ํด๋ฆฌ์ผํ๋นํ๋๋ฅ
- ํ์
- ํ์ / ํ์์จ
- ํก๋จ์ฐ๊ตฌ
- ํจ์
- ํจ์๋ฉด์ญ๊ฒ์ฌ
- ํจ์ํ์๋ฉด์ญ์ธก์ ๋ฒ
- ํ๊ฒฌ์ธ
- ํํฅ์ ๊ฒ์ฆ / ํ๊ณ ์ ๋ฐธ๋ฆฌ๋ฐ์ด์
- ํก์
๋
ธ์ถ
- ํก์
์ฉ๋
- ํก์
๋
์ฑ์ํ
- ํก์
- ํก์ ๊ณ์
- ํก์ ๋ฐฑ๋ถ์จ
- ํก์ ์ฅ๋ฒฝ / ๊ด๋ฌธ
- ํก์๋ถ์จ
- ํก์์ ๋ ๋๋ ์ฉ๋
- ํก์ฐฉ
- ํฌ๋ก๋งํ ๊ทธ๋ํผ
- ํฌ๋กฌ
- ํด๋ ๋ถํ
๋กค
- ํด๋ก๋ํ๋์ฝ
- ํด๋ก๋ฅดํผ๋ฆฌํฌ์ค
- ํด๋ก์คํธ๋ฆฌ๋์๊ท
- ํค๋ก๊ฑฐ
- ํ์
- ํ๋น์ฑ ์กฐ์ฌ
- ํ๋ง๋ฆฐ
- ํฐ๋ธํฌ์ค
- ํ
ํธ๋ผ์ธ์ดํด๋ฆฐ
- ํก์์ด๋
- ํจ๋ฃจ์
- ํต๊ณ์ ์ ์์ฑ
- ํต๊ธฐ๊ตฌํํฐ, ๋ฒคํธํํฐ
- ํต์์ฅ๋ฒฝ๊ท์
- ํฌ์ฌ ๊ฒฝ๋ก
- ํฌ์ฌ๋
- ํ๋ณธ๋ถ์ฐ
- ํ์
- ํ์ ๊ธฐ๊ด
- ํ์ ๊ธฐ๊ด ์ฉ๋
- ํ์ ์ง๋จ
- ํ์ ์ง๋จ
- ํ์
- ํ์ค ์์
์ง์นจ์
- ํ์ค ์ค์ฐจ
- ํ์ค ํธ์ฐจ
- ํ์ค๋ฌผ์ง
- ํ์ค์ด์์ง์นจ
- ํ์ค์์๊ด๋ฆฌ๊ธฐ์ค
- ํ์ค์น๋ฃ๋ฒ
- ํธ๋์ฒด์ธ
- ํธ๋ชจ๋์
- ํ์ง ๋ชฉํ ์ ํ ํ๋กํ
- ํ์ง ๋ณด์ฆ
- ํ์ง๋ฆฌ์คํฌ๊ด๋ฆฌ, ํ์ง์ํด ์์๊ด๋ฆฌ
- ํจ๋
- ํ๋ผ๊ทธํ์ฑ์ํ
- ํ๋ผ์ค๋ฏธ๋
- ํ๋๊ทธ
- ํ๋ฃจ์ค๋ ์ธ์ธ ์๋ฅ๋
- ํ๋์ค ์ํ์์ ์ฒญ
- ํ๋กํ ์ฝ ๋๋ ์ํ ๊ณํ์
- ํ๋ฆฌ์จ์ด
- ํ๋ฆฌ์จ
- ํํ๋ ์ดํธ
- ํผ๋จ
- ํผ๋ถ ๋
ธ์ถ
- ํผ๋ถ ์ ์ฐฉ/๋ถ์ฐฉ
- ํผ๋ถ ํก์ ์ฉ๋
- ํผ๋ถ ํก์, ํผ๋ถ ์นจํฌ
- ํผ๋ถ๊ฐ์์ฑ์ํ
- ํผ๋ถ์ผ์ฐจ์๊ทน์ํ
- ํผ๋ถ์๊ทน
- ํผ์ฑ
- ํผ์นด
- ํผํฌํผ
- ํ๊ตญ๋๋ฌผ๋์ฒด์ํ๋ฒ ๊ฒ์ฆ์ผํฐ
- ํ๊ตญ๋๋ฌผ๋์ฒด์ํ๋ฒ๊ฒ์ฆ์ผํฐ
- ํ๊ตญ์ธ์ ๊ธฐ๊ตฌ
- ํ์์ ๊ธฐ์ค ๋ฐ ๊ท๊ฒฉ
- ํํฅ์ ์ ๊ทผ๋ฐฉ์
- ํ ๋๊ฒ์ฌ
- ํจ๋ ๋๋ ์ญ๊ฐ์ํ
- ํจ๋, ์ญ๊ฐ, ๊ฐ๋
- ํฉ๋ฆฌ์ ๋ถ์๋ฒ
- ํฉ๋ฆฌ์ ์ต๋ ๋
ธ์ถ
- ํฉ๋ชฉ์ ์ฑ
- ํญ๊ท ์
- ํญ์์ฑ์ํ
- ํญ์์
- ํญ์์ ๋ค์ ์ ํญ์ฑ
- ํญ์ฒดํ์ค๋๋์ํ
- ํด, ์ํด
- ํต์ฐ์ฆํญ๊ฒ์ฌ
- ํ์ ๋ฌด๋ฅ๋ ฅ์
- ํฅ์ ์ ์ฑ์์ฝํ
- ํ๊ฐ ์ธ ์ฌ์ฉ ์์ฝํ
- ํ์ฉ ์ฉ๋
- ํ์ฉ์ํ์ญ์ทจ๋
- ํคํ
๋ก์ฌ์ดํด๋ญ์๋ฏผ
- ํคํ
๋ก์ฌ์ดํด๋ฆญ์๋ฏผ๋ฅ
- ํฌ๋ฆฌ์ฝฅํฐ ์ฐ๊ตฌ
- ํตํํฌ๋ก
- ํ์ฅ ์ฐ๊ตฌ, ํ์ง ์ฐ๊ตฌ
- ํ์ฅ๋ถํ์ ์
- ํ์กํ์ ๊ฒ์ฌ
- ํ์ฒญ ์ ํ
- ํ๋์์ฉ
- ํ์ ๊ฐ
- ํ์ง์ ํ ๋๋ฌผ
- ํํํ
- ํธ๋ ๊ฐ
- ํธ์ฃผ ๋์ฝ․๋๋ฌผ์ฉ์์ฝํ๊ตญ
- ํธ์ฃผ․๋ด์ง๋๋ ์ํ๊ธฐ์ค์ฒญ
- ํธํก์ฑ ๋ถ์ง
- ํน์ค, ์์๋ฉ์์ง
- ํผํฉ๋ฐฑ์
- ํํ ์ด๊ท ์
- ํํ๋ฌผ์ง ์์ ์ ๊ดํ ๊ตญ์ ํ๋ก๊ทธ๋จ
- ํํ๋ฌผ์ง์ ๊ตญ์ ์ ๊ด๋ฆฌ ์ ๋ต
- ํํ๋ฌผ์ง์ ๋ถ๋ฅ ๋ฐ ํ์์ ๊ดํ ์ธ๊ณ์กฐํ์์คํ
- ํํ์ ์ ํด์ํฅ์ ๋ฐ์ธ์
- ํํ์ ํฉ์ฑํ
- ํ๋ฅ ๋ก ์ ๋ถ์
- ํ๋ฅ ๋ก ์ ๋ถํ(์ค)๋ ๋ถ์
- ํ์ธ์ํ
- ํ์ฅ์ฑ
- ํ์ฅ์ธก์ ๋ถํ๋
- ํ๊ฒฝ ๊ฐ์ /ํ๋ถํ
- ํ๊ฒฝ ์ ๋ ์๋ฅํ์ฉ๊ธฐ์ค
- ํ๊ฒฝ๋ชจ๋ํฐ๋งํ๋ก๊ทธ๋จ
- ํ๊ฒฝ์ ๊ฒฝ๋ก
- ํ์์
- ํ์ - ๋์กฐ๊ตฐ ์ฐ๊ตฌ
- ํ์์ ๋
- ํ์์ ๋ ๊ถ๊ณ ๊ธฐ์ค
- ํํํ์๊ฒฝ์ ๋๋ฐ์ํ๋ ฅ์ฒด์
- ํฉ์ํฌ๋์๊ตฌ๊ท
- 01 ์จ๋ถ๊ด๊ธฐ
- 1์ฐจ ํ์คํ
- 2์ฐจ ํ์คํ
- 3-MCPD
- 3-Monochloropropane-1,2-diol,
- 3Rs ์์น: ๊ฐ์, ๋์ฒด ๋ฐ ๊ฐ์
- 1,3-Dichloro-2-Propanol
- 50%์กฐ์ง๋ฐฐ์๊ฐ์ผ๋/ ์ค๊ฐ์กฐ์ง๋ฐฐ์๊ฐ์ผ๋
- 50% ๋
์ฑ๋
- 50% ๊ฐ์ผ๋
- Aํ ๊ฐ์ผ๊ณผ Eํ ๊ฐ์ผ
- Absorbed Dose
- Absorbed dose
- Absorption
- Absorption Barrier
- Absorption barrier
- Absorption Factor
- Absorption factor
- Absorption Fraction
- Absorption fraction
- Absorption percent
- Accelerated Testing
- Acceptable daily intake, ADI
- Acceptance Criteria
- Accuracy
- Acelerated Testing
- Acetaldehyde
- Acetaldehyde
- Acidity Regulator
- Acrylamide
- Acrylonitrile-butadiene-styrene, ABS
- Action level
- Active ingredient
- Active pharmaceutical ingredient (API)
- Active Systemic Anaphylaxis Test
- Actual yield
- Acute exposure
- Acute Population Adjusted Dose, aPAD
- Acute Reference Dose, ARfD
- Acute toxicity
- Acute Toxicity Test / Study
- Ad libitum
- ADI not allocated
- Adjuvant
- Administered Dose
- Administered dose
- Adsorption
- Advanced Electronic signature
- Adverse effect
- Adware
- Aflatoxin
- Agence Francaise de Securite Sanitaire des Aliments, AFSSA
- Agent
- Aggregate exposure
- Agreement on the Application of Sanitary Phytosanitary Measure
- Agreement on the application of sanitary phytosanitary measure, SPSํ์
- AHWP; Asian Harmonization Working Party
- Airlock,
- Alcohol
- Aldrin / Dieldrin
- Alert limits (environmental monitoring)
- Alert limits (media fill)
- Alkyl phenol
- Alkyl phenol
- Allergic reaction
- Alternative Carcinogenicity Study
- Alternative Test Method
- Aluminium
- American Society for Testing and Materials, ASTM
- Ames test, reverse mutation test using bacterial system
- Amitraz
- Ampicillin
- Ampicillin
- Analgesia
- Analgesics
- Analysis of variance
- Analyte
- Analytical Procedure
- Anesthesia
- animal experimentation
- Animal Husbandry
- Animal Model for Human Disease
- animal model(s)
- Animal Rights
- animal testing alternative(s)
- animal wellbeing / well-being
- ANSI; American National Standards Institute
- Antagonism
- Antibiotics
- Antifoaming Agent
- Antigenicity Test
- Antimicrobial
- Antimicrobial Resistance
- Antimicrobial resistance
- Antioxidant
- Antiseptic
- AOAC
- API Starting Material
- Apparatus / Container and Package
- Applicability
- Application
- Application- Specific Software
- Appropriate Level Of Protection, ALOP
- ARfD ; Acute Reference Dose
- Arsenic
- artificial intelligence
- artificial organ(s)
- As Low As Reasonably Achievable, ALARA
- Aseptic filling
- Aseptic techniques and manipulations
- Asian Harmonization Working Party, AHWP
- Assay : Content or Potency
- Association for Assessment and Accreditation of Laboratory Animal Care, AAALAC
- Association of South-East Asian Nations, ASEAN
- ASTM; American Society for Testing and Materials
- Asymmetrical frequency distribution
- Attack rate
- Australian Pesticides and Veterinary Medicines Autority, APVMA
- Authorized person
- Autocorrelation
- Automated System
- Average life expectancy
- Avian / Bird Influenza(Flu)
- Bacillus cereus, B. cereus
- Background level
- Bacteriostasis)
- Bacterium (๋ณต์ํ : Bacteria)
- Barrier
- BAs; Biogenic Amines
- Batch Number (or Lot Number)
- Batch ( or Lot )
- Batch records
- Becquerel, Bq
- Benchmark dose, BMD
- Benchmark substance
- Benzene
- Benzo[a]pyrene, BaP
- Bespoke
- Best before date
- BfArM; Federal Institute for ฮฑugs and Medical Devices
- BfR
- Bias
- Bifenthrin
- Bimodal distribution
- Bio Chip
- Bioaccumulation
- Bioavailability (BA)
- Bioavailability Evaluation
- Bioavailabilty
- Bioburden
- biochemistry
- Biocide
- Bioconcentration Factor, BCF
- Biodegradation
- Bioequivalence Test
- bioethics
- Biogenerator
- Biogenic amines, BAs
- Bioindicators
- bioinformatics
- Biological Agents
- Biological Indicator
- Biological Marker
- Biological Medium
- Biological Monitoring, Biomonitoring
- Biological uptake
- Biologically Based Dose Response, BBDR
- Biomarker
- Biophysics
- Biopsy
- Biosimilar Product
- Biotechnol์ical Products/Biological Products
- Biotransformation
- Bisphenol A
- Blinding/Masking
- Body burden
- Body Weight, B.W.
- Booster vaccination
- Bottom-up approach
- Botulism
- Botulism
- Bounding estimate
- Bovine Spongiform Encephalopathy, BSE
- BRA/BRBA; Benefit-Risk (Balance) Assessment
- Bridging Study
- Brucella
- BSE๊ฒ์ฌ๋ฒ
- Bug
- Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit, BVL
- Bundesinstitut fur Risikobewertung, BfR
- Bundesinstiut fur Risikobewertung, BfR
- Bundesministerium fur Emahrung Landwirtschaft und, Verbraucherschutz, BMELV
- Cadmium
- Calibration
- Campylobacter jejuni, Campylobacter col
- Canadian Food Inspection Agency, CFIA
- CAPA; Corrective Action and Preventive Action
- Carcinogenicity
- Carcinogenicity Study
- Carry - Over
- CAS ๋ฑ๋ก๋ฒํธ
- CAS(Chemical Abstracts Service) Registry Number
- Case - control study
- CBER; Center for Biologics Evaluation and Research
- CDC; Center for Disease Control and Prevention
- CDER; Center for Drug Evaluation and Research
- CDISC; Clinical Data Interchange Standard Consortium
- CDRH; Center for Devices and Radiological Health
- cell fractionation
- cell line(s)
- Cell Therapy Products
- cells
- Center for Food Safety and Applied Nutriton, CFSAN
- Centers for Disease Control and prevention, CDC
- Certified reference material, CRM
- CFE; Colony Forming Efficiency Test
- CFSAN; Center for Food Safety and Applied Nutrition
- CFSCR; Center for Food Safety Consumer Report
- Chemical germicide
- Chemical stressors
- Chemically synthesized compounds
- Childrenโs Dietary Life Safety Index
- Childrenโs Favorite Foods
- Childrenโs Food Safety and Protection Zones
- Childrenโs Meal Service Support Centers
- Chloramphenicol
- Chlorpyrifos
- Chromatography
- Chromium
- Chromium
- Chromosome Aberration Test
- Chromosome aberration test
- Chronic Exposure
- Chronic Population Adjusted Dose, cPAD
- Chronic Reference Dose, cRfd
- Chronic Toxicity
- Chronic Toxicity Test / Study
- CID; Comron Technical Docurrents
- Ciprofloxacin
- Ciprofloxacin
- Class of cleanliness
- Clean Area
- Clean / Contained of Area
- Clean room
- Clean Zone
- Cleaning Validation
- Clenbuterol
- Clinical Data Interchange Standard Consortium, CDISC
- Clinical Trial / Study
- Clostridium perfringens
- Cmax
- Cmax
- CND; Commission on Narcotic Drugs
- Cobalt
- Code of Federal Regulations, CFR
- Codex Alimentarius Commision, CODEX
- Codex; Codex Alimentarius
- Coefficient of variation
- Cohort
- Cohort
- Coliform Group
- Colony Forming Unit (CFU)
- Color Retention Agent
- Combination Preparation
- combination vaccine
- Commercial of the shelf software
- Common Technical Document, CTD
- Comparator/Control Drug
- Compliance Monitoring
- Component
- Compounding
- Concentration - Effect Curve
- Conceptual model
- Confidence interval
- Confidence limit
- Conflict of interest
- Confounding
- Contact rate
- Contained Area
- Containment
- Contaminant
- Contaminants in Food
- Contamination
- Continuous time model
- Contol Number
- control number / Lot number / batch number
- Control Strategy
- Controlled Area
- Conventional quantity value
- Cornea
- Corneal opacity
- Corneal swelling
- Corrective Action
- Correlation
- Correlation coefficient
- Crisis
- Crisis management
- Critical Area
- Critical operation
- Critical Quality Attribute
- Critical surfaces
- Critical value
- Critical zone
- Cronobacter spp.
- Cronobacter spp.
- Cross contamination
- Cross-Sectional Study
- Cross-sectional study
- Cumulative Exposure
- Cumulative exposure assessment
- CVM; Center for Veterinary Medicine
- Cypermethrin
- Cytogenetics Evaluation
- Cytotoxicity Test
- D ๊ฐ
- D value
- Dairy Product
- DCP
- DDT
- Debugging (IEEE)
- Decontamination
- Defining (empirical/conventional) method of analysis
- DEHA
- DEHP
- Delayed type hypersensitivity test
- Delayed Type Hypersensitvity Test
- Delivered Dose
- Delivered dose
- Demography
- Deoxynivalenol, DON
- Deoxyribonucleic Acid
- Deoxyribonucleic Acid
- Department for Environment, Food and Rural Affairs, DEFRA
- Department of Veterans Affairs, VA
- Depyrogenation
- Dermal Absorption, Dermal Penetration
- Dermal absorption, Dermal penetration
- Dermal Exposure
- Dermal exposure
- Dermaliy Absorbed Dose
- Dermally absorbed dose
- Detection system of BSE
- Deterministic Analysis
- Deterministic model
- developmental toxicity
- Di-(2-ethylhexyl)-adipate, DOA
- Di-(2-ethylhexyl)-phthalate, DOP
- diagnosis
- Diazinon
- Dichloro-Diphenyl-Trichloroethane
- Dietary supplements
- Diethylstilbestrol, DES
- Diethylstilbestrol, DES
- Dioxins
- Direct Microscopic Count/Direct Microscopy
- Disinfectant
- Disinfection
- Disintegration Test
- distilled water
- Distribution
- Distribution - free method
- DMF; Drug Master File
- DNA
- Dose
- Dose
- Dose Adjustment
- Dose - Effect
- Dose - Effect Curve
- Dose - Response
- Dose - Response Assessment
- Dose-Response Assessment
- Dose - response assessment
- Downer Cow
- DQ; Design Qualification
- Drinking water exposure
- DRL; Diagnostic Reference Level
- Drosophila Melanogaster
- Drug
- drug antagonism
- drug combination(s)
- drug development
- drug evaluation
- drug interaction(s)
- Drug Product
- drug residue(s)
- Drug Substance
- drug synergy / synergism
- drug therapy
- drug toxicity
- Dry solid
- Duplicated method, tray for absent one
- Dynamic
- E-screen ์ํ๋ฒ
- E-screen assay
- E-screen assay ์ํ๋ฒ
- E-scren Asay
- EC ๊ณผํ์ด์์์
- EC ๊ณผํ์ด์์์ํ
- EC Scientifc Stering Committee, EC SSC
- EC Scientific Steering Committee, EC SSC
- ecotoxicology
- ECVAM
- EDCs/EDs ;Endocrine Disrupting Compounds/Endocrine Disruptors
- Effect Dose, ED10
- Effective component of disinfectant
- Efficacy Study
- EIA ; Enzyme lmmuno Assay
- ELISA
- Embryo
- Embryo Culture Techniques
- Encryption
- End-to-End Communications
- Endocrine Disrupters
- Endosulfan
- Endotoxin
- Endpoint
- Enrichment Culture
- Enteric-Coated Products
- Enterobacteriaceae
- Enterohemorrhagic Escherichiacoli, EHEC
- Environmental Enrichment
- Environmental monitoring programme
- Environmental pathway
- Environmental Protection Agency, EPA
- Environmental Protection Agency, EPA
- Enzyme
- Enzyme
- Enzyme-Linked Immuno-Sorbent Assay, ELISA
- Enzyme-Linked Immuno-Sorbent Assay, ELISA
- Enzyme-Linked Immunosorbent Assay
- EPA; Environmental Protection Agency
- Epidemiological Survey
- Epidemiology
- EPN ; Ethyl p-nitrophenyl phenylphosphorothioate
- ER; ๋นtended-Release Forms/Prolonged Release Forms
- ER binding assay
- ER binding assay
- Error
- Erythromycin
- Erythromycin
- ESBL -Producing Shigella Sonnei
- Establishment Inspection Report, EIR
- Estimated Daily Intake, EDI
- Estimated Exposure Dose, EED
- Estimated Exposure Dose, EED
- Estimated Maximum Daily Intake, EMDI
- Ethyl carbamate
- European Centre for Validation of Alternative Methods, ECVAM
- European Commission, EC
- European Commission, EC
- European Committee for Standardization, CEN
- European Food Safety Authority, EFSA
- European Medicines Agency, EMA
- European Medicines Agency, EMEA
- European Union, EU
- Evaporation residue
- Excretion
- Exemption
- Expanded measurement uncertainty
- Expedited Review
- Experimental Animal
- Explant
- Exposure
- Exposure Asesment
- Exposure Assessment
- Exposure concentration
- Exposure dose Reconstruction
- Exposure duration
- Exposure event
- Exposure frequency
- Exposure Indicator
- Exposure Limits
- Exposure pathway
- Exposure point
- Exposure potential
- Exposure Profile
- Exposure route
- Exposure Scenario
- Exsanguination
- Extracts
- Extraneous Maximum Residue Limits, EMRL
- Eye irritation study
- Fabrication
- False negative rate
- False positive rate
- Falsification
- FAO / WHO ํฉ๋ ๋ฏธ์๋ฌผํ์ ์ํด ํ๊ฐ ์ ๋ฌธ๊ฐ ํ์
- FAO/WHO ํฉ๋ ์ํ์ฒจ๊ฐ๋ฌผ ์ ๋ฌธ๊ฐํ์
- FAO/WHO ํฉ๋ ์๋ฅ๋์ฝ ์ ๋ฌธ๊ฐํ์
- FDA; Food and Drug Adminstration
- FDAAA; FDA Amendment Act
- Feasibility Study
- Federal Trade Commission, FTC
- Feed additive
- Female Pubertal Onset Assay
- Fertility and early embryonic development study
- Fertilty and Early Embryonic Development Study
- Fetuses
- Fiber
- Field Study
- Final Report
- Finished Product
- Firewalls
- Fitness for purpose
- Flag
- Fluid Extracts
- Fluorescein retention
- Fluorine
- FMD; Foot and Mouth Disease
- Focus Group
- Food additive
- Food and Drug Administration, FDA
- Food chain
- Food consumption
- Food diary
- Food Hygiene
- Food hygiene (sanitation) inspection organization
- Food Materials
- Food poisoning, Foodborne illness
- Food poisoning index
- Food Recall
- Food Safety and Inspection Service, FSIS
- Food Safety Objective, FSO
- Food Sanitation Deliberation Council
- Food Standards Agency, FSA
- Food Standards Australia New Zealand, FSANZ
- Food tar color
- Food traceability
- Foodborne Disease Early Warning Systsm
- Foodborne Disease management Systsm
- Foodborne pathogen
- Foods, etc. Detrimental to Childrenโs Emotional Health
- Foods for special dietary use
- Forgery
- Formalin
- Formalin
- Fragmentation
- Freedom of Information Act
- Freeware
- FSMA; Food Safety Modern Act
- Full Boards Review, Full Committee Review
- Fumonisin
- Function
- Functional Cosmetics
- Functional Health Foods
- Functional Ingredient
- Functionality
- Functionality Rating
- Furan
- GCP(Good Clinical parctice)
- Gene
- Gene
- Gene Bank
- Gene Therapy Products
- General Pharmacology Study on the CNS (Central Nervous System)
- General pharmacology study on the CNS(Central Nervous System)
- General population
- General Safety Test, GST
- General Toxicity
- General Toxicity Study
- Generally Recognized As Safe, GRAS
- Generic Drug
- Generic Drugs
- Genetic Determinism
- Genetic Exceptionalism
- Genetically Modified foods, GM foods
- genetics
- Genome
- Genomics
- Genotoxic Carcinogen
- Genotoxic carcinogen
- Genotoxicity
- Genotoxicity
- Genotoxicity Test, Genetic Toxicity Test
- Genotyping
- Ghost Author
- Gift Author
- Glazing
- Globally Harmonized System of Classification and Labelling of Chemicals, GHS
- GLP(Good Laboratory Practice)
- Glutathione Peroxidase Assay
- GMO
- God Laboratory Practice, GLP
- God Veterinary Drug Practice, GVDP
- Good Agricultural Practice, GAP
- Good Clinical Practices, GCP
- Good Hygiene Practices, GHP
- Good Laboratory Practice, GLP
- Good Manufacturing Practice for Medicinal Products (GMP)
- Good Manufacturing Practices, GMP
- Good Research Practice, GRP
- Good Veterinary Drug Practice, GVDP
- Gowning Qualification
- Gram Staining
- Growth promotion test
- Guardian
- Guinea pigs
- Half-Finished Product
- Half - life
- Harm
- Hazard
- Hazard Analysis and Critical Control Point, HACCP
- Hazard Characterization
- Hazard characterization
- Hazard Identifcation
- Hazard Identification
- Hazard identification
- Hazard Index
- Hazard Index
- HbGV; Health based Guidance Value
- HCAs; Heterocyclic Amines
- Health Based Guidance Value, HBGV
- Health Canada
- Health functional food
- Helicopter Research
- Hematological Examination
- Hematological examination
- HEPA filter / High efficiency particulate air filter
- HEPAํํฐ, ๊ณ ์ฑ๋ฅ๋ฏธ๋ฆฝ์๊ณต๊ธฐํํฐ, ๊ณ ์ฑ๋ฅ๊ณต๊ธฐํํฐ
- Hepatitis A Virus, HAV / Hepatitis E Virus, HEV
- Heptachlor
- Herbal Substances
- Hershberger Assay
- Heterocyclic amines, HCAs
- HHS; Department of Health and Human Services
- High-Calorie Low-Nutrient Foods
- High - end exposure (dose) estimate
- High Pathogenic Avian Influenza
- High Performance Liquid Chromatography, HPLC
- HMP; Herbal Medicinal Product)
- Hoax
- HorRat
- Household interview survey
- HSA; Human Serum Albumin
- Human Biomonitoring
- Human equivalent concentration, Human equivalent dose
- Human exposure evaluation
- Human Research Protection Program, HRPP
- Human Subject
- Human Subjects Research
- Human Tissue
- HVAC
- Hygiene Index Bacteria
- ICNIRP
- ICRP; International Commission on Radiological Protection)
- Identification Test
- Identifier
- IEC; International Electrotechnical Commission
- IMD : Incrementally Modified Drug
- Immunity
- Immunogenicty
- Immunology
- Immunotoxicity
- Immunotoxicity Study
- IMO; Incrementally Modified Drug
- Impartial Witness
- Impurity
- Impurity Profile
- IMS; Ion Mobility Spectrometry
- In-process material
- In situ
- In vitro
- In vivo
- Inactive ingredient
- Incidence
- Incidental ingestion
- Incompetent Adult
- Incrementally Modified Drug, IMD
- Incubators
- Independent Ethics Committee, IEC
- Indirect contact
- Indirect exposure
- Indirect exposure
- Infecting Dose 50%, ID50
- Infecting Dose 50%, ID50
- Infectious agent
- Infinite dose
- Informed Consent
- Informed Consent Form, ICF
- INFOSAN; International Food Safety Authorities Network
- Inhalation Exposure
- Inhalation exposure
- Inhalation Toxicity Study
- Inhalation Toxicity Study
- Inhaled dose
- Inhaled dose
- Inhibitory Concentration 50
- Inspection
- Inspection of Broken Eggs
- Instantaneous Point Exposure
- Institute of Medicine, IOM
- Institutional Animal Care and Use Committee, IACUC
- Institutional Animal Care Committee, IACUC
- Institutional Review Board, IRB
- Instiute Laboratory Animal Resource, ILAR
- Instiutional Animal Care Committee, IACUC
- Intake
- Intake dose
- Intake rate
- Inter-laboratory study
- Interaction
- Interface
- Interim Clinical Trial/Study Report
- Intermediate
- Intermediate duration exposure
- Intermediate Precision
- Internal Esposure
- Internal Exposure
- International Agency for Research on Cancer, IARC
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH
- International Cooperation on Alternative Test Methods, ICATM
- International Numbering System, INS
- International Organization for Standardization, ISO
- International Program on Chemical Safety, IPCS
- International Program on Chemical Safety, IPCS
- Intervention
- Intoxication, Addiction
- Invasion of Privacy
- Invertebrates
- Investigational Drugs
- Investigational new drug
- Investigational New Drug application
- Investigational Products
- Investigator
- Investigator Brochures, IB
- Investigator-Initiated Studies
- Investitational Device
- Iodine
- IOM ; Institute of Medicine
- Ionizing Radiation
- IQ; Installation Qualification
- Irraidated Food
- ISO9000 ์๋ฆฌ์ฆ
- ISO9000 series
- Isolator
- IT; Import Tolerance
- JaCVAM
- Japanese Centre for the Validation of Alternative Methods
- JIFSAN;Joint lnstitue for Food Safety and Applied Nutrition
- Joint Commission
- Joint FAO/WHO Expert Committee on Food Additves, JECFA
- Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment, JEMRA
- Joint FAO/WHO Meeting on Pesticide Residues, JMPR
- Jugular Veins
- Ka.AS; Korea Laboratory Acreditation Scheme
- Kastuobushi
- Key Logger
- KHP; The Korean Herbal Pharmacopoeia
- KoCVAM;Korean Center for the Validation of Alternative Methods
- Korean Center for the Validation of Alternative Methods, KoCVAM
- KP; Korean Pharmacopoeia
- KPC; Korean Pharmacopoeia! Codex
- Laboratory Animal
- Laboratory-performance (proficiency) study
- Laparotomy
- Large-volume parenterals
- Late Effects
- Lateral Saphenous Vein
- Lead, Pb
- Legally Authorized Representative, LAR
- Lethal concentration 50%, LC50
- Lethal Dose 50%, LD50
- Lethal Dose, LD
- Lethal Dose, LD
- Life cycle
- Limit of Detection, LOD
- Limit of Quantitation, LOQ
- Linear model
- Linearity
- Liquifiable Gases
- Listeria
- Listeria Monocytogenes
- Listeria monocytogenes food poisoning
- Livestock Product Hygine Deliberation Committee
- lmmunotoxicity Study
- LOAEL; Lewest Observed Aderse Effect Level
- Local Iritation Study
- Local irritation study
- Local tolerance test
- Log - normal distribution
- Longitudinal Study
- Look-Back
- Loop Testing
- Lot
- Lot Number
- Lowest Acceptable Daily Dose, LADD
- Lowest Observed Adverse Effect Level, LOAEL
- Lowest Observed Adverse Effect Level, LOAEL
- Malachite Green
- Malware
- Manganese
- Manifold
- Manufacture
- Manufacture, processing, packing or holding of a drug product
- Manufacturer
- Margin of Exposure, MOE
- Margin of safety
- Market basket
- Marketing authorization (product licence, registration certificate)
- Master formula
- Master record
- Material
- Material-certification Study
- material test
- Mathematical Model
- Mathematical Model
- Maximally exposed individual
- Maximum Dose
- Maximum Dose
- Maximum exposure limit, MEL
- Maximum exposure range, MER
- Maximum level, ML
- Maximum Residue Limit, MRL
- Maximum Residue Limits of Veterinary Drugs, MRLVD
- Maximum Residue Limits of Veterinary Drugs, MRLVD
- Maximum Tolerance Dose
- Mean
- Measurand
- Measure against food terrorism
- Measure of Exposure
- Measurement method
- Measurement procedure
- Measurement uncertainty
- Meat Product
- MED ; Minimum Erythema Dose
- Media fills
- Median
- Medical Device Committee
- Medical Device Subject to Tracking
- Medicinal Product
- Medium (pl. media)
- Melamine
- MERCOSUR; Mercado Comun del Sur
- Metabolic Syndrome
- Metabolism
- Metabolism phase โ
Reaction
- Metabolism phase โ
ก Reaction
- Metagenome
- Metalaxyl
- Method-performance study
- Methodology
- Methylmercury
- Metrological traceability
- MFN; The Most Favored Nation
- Microbicide
- Microbiology
- Micronucleus Test
- Migrant Specification
- Migration test
- Milk Solid
- Minimal Risk Level, MRL
- Minimal Risk Level, MRL
- Ministry of Health, Labor, and Welfare, Japan
- Mixture
- Mode
- Model
- Model Validation
- Moderator variable
- Molecular Biology
- Monitoring
- Monitoring Report
- Monoclonal Antibodies
- Monoclonal Antibody
- Monte Carlo Simulation
- Moral Hazard
- Morphology
- Most-Favored Nation Treatment
- Mother Liquor
- MOU; Memorendum of Understanding
- MRA; Mutual Recognition Agreement
- Multicellular organism
- Multimedia exposure
- Multiple Antibiotic Resistance
- Mutagen
- Mycotoxins
- NAFTA; North American Free Trade Agreements
- Nano-bio functional material
- Nano biomimetic material
- Narcotics
- NARMS;National Anti-microbial Resistance Monitoring System
- NAs; Nitrosamines
- NAT; Nucleic Acid Amplification Test
- National Center for Toxicological Research, NCTR
- National Institute of Environmental Health Science, NIEHS
- National Institutes of Health, NIH
- National Lot Release
- National Toxicology Program, NTP
- Natural flavoring substances
- Natural food additives
- Natural toxin
- NCTR; National Center for Toxicological Research)
- Negative control
- Neurobiology
- Neurology
- New Drug Application, NDA
- NIBSC
- NICEATM
- Nickel, Ni
- NIH; National Institutes of Health
- nitiation
- Nitrofuran
- Nitrofuran
- Nitrosamine
- No Observed Adverse Effect Level, NOAEL
- No Observed Effect Level, NOE
- No Observed Effect Level, NOEL
- Non-Fat Milk Soli
- Non-Ionizing Radiation
- Non - Linear Dose Response
- Non - threshold
- Nonclinical Test, Non - Clinical Laboratory Studies
- Nonclinitcal evaluation of vaccines
- Nonfiber releasing filter
- Normal distribution
- Norovirus
- Novel food
- Nutrient supplement food
- Nutrition Claim
- Nutrition Facts
- Occupational exposure limit, OEL
- Ochratoxin A, OTA
- OECD
- OECD ๋๋์์ฐํํ๋ฌผ์ง ์ ํด์ฑ ํ๊ฐ์ฌ์
- OECD Screening Information Data Set, OECD SIDS
- OECD Screening Information Data Set, OECD SIDS
- OECD WPMN
- Off-Label Drug
- Offal Meat
- Office for Human Research Protections, OHRP
- Office International des Epizooties, OIE
- Official Compendium/Pharmacopoeia
- OIE; Office International des Epizooties
- One Serving Size
- Operating Environment
- Optically Active Drug
- OQ; Operational Qualification
- Oral exposure, Ingestion
- Oral mucosal iritation study
- Oral mucosal irritation study
- Orange II
- Organ Culture
- Organ Culture Techniques
- OTC; Over The Counter
- Other Ingredients
- Out of Specification
- Outlier
- Outsourced Activities
- Overkill sterilization process
- Oxytetracycline
- Oxytetracycline
- PA; Protection Grade of UVA
- Packaging
- Packaging Material
- PAHs; Polycyclic Aromatic Hydrocarbons
- Paralytic shellfish poison, PSP
- Parametric Release
- Parasitology
- Passive Cutaneous Anaphylaxis Test
- Patching
- Pathogenic Escherichia coli
- Pathogenic Escherichia coli
- Pathogens
- Patient Dose
- Patulin
- PCR; Polymerase Chain Reaction
- Peer Review
- Peer-to-Peer, P2P
- Per capita intake rate
- Percentage of theoretical yield
- Percutaneous absorption
- Performance Indicators
- Performance Qualification (PQ)
- Permissible dose
- Permissible dose
- Permissible exposure limit, Permissible exposure
- Persistent Organic Pollutants, POPs
- Personalized Medicine, PM
- Pesticide residue
- Pharmaceutical Isolator
- Pharmaceutical product
- Pharmaceutical Products Test and lot Release
- Pharmaceutical Quality System (PQS)
- Pharmaceuticals Required for Data Submission
- Pharmacodynamics
- Pharmacogenetic Information
- Pharmacokinetic model
- Pharmacokinetic Study
- Pharmacokinetic study
- Pharmacokinetics
- Pharmacokinetics
- Pharmacological test
- Pharmacovigilance, PV
- Phase 1 Clinical Trials
- Phase 2 Clinical Trials
- Phase 3 Clinical Trials
- Phishing
- Phosphatase
- Phototoxicity
- Phthalate
- Physiologically Based Pharmacokinetic Model, PBPK
- Physiology
- Pica
- Pidan
- Placebo
- Plagiarism
- Plaque - Forming cel Test
- Plaque - forming cell test
- Plasma
- Plasma Derivative
- Plasma Master ํฐle)
- Plasmid
- PLS; Positive List System
- PMDA; Pharmaceuticals and Medical Devices Agency
- Point estimate
- Point - of - Contact Exposure
- Point - of - contact exposure
- Point Of Departure, POD
- Poison
- Polychlorinated biphenyls, ์ดํ PCBs
- Polyclonal Antibodies
- Polycyclic aromatic hydrocarbons, PAHs
- Polymerase Chain Reaction, PCR
- POPs; Persistent Organic Pollutants
- Population
- Population
- Positive control
- Potency
- Potential dose
- Potentially exposed
- Poultry
- PQ; Pe์
ormance Qualification
- Pre-Review
- Precision
- Predictive Food Microbiology Model
- Predictive Model
- Predictive model
- Preimplantation Embryo Culture Method
- Preimplantation embryo culture method
- Preliminary risk management activities
- Preservative
- Preserved Foods
- Preventive Action
- Primary Skin Irritation Study
- Primary Skin Irritation Study
- Primary vaccination
- Prion
- Probabilistic analysis
- Probabilistic uncertainty analysis
- Probabilstic Analysis
- Probabilstic Uncertainty Analysis
- Procedure(s)
- Process Aids
- Process Validation
- Product characterization
- Product Lifecycle
- Product Realisation
- Production
- Proficiency Testing
- Proliferation Assay
- Promotion
- Prospective Validation
- Protocol
- Protocol or plan
- Proven Acceptable Range
- Provisional Maximum Tolerable Daily Intake, PMTDI
- Provisional Tolerable Monthly Intake, PTMI
- Provisional Tolerable Weekly Intake, PTWI
- PSP; Paralytic Shellfish Poision
- Psychotropics
- PTWI; Provisional Tolerable Weekly Intake
- Purity Test
- Purity Test
- Purpose-Bred Animal
- Pyrogen
- Pyrogen Test
- QRS; Quick Repair Service
- Qualitative Data
- Qualitative data
- Qualitative Risk Assessment
- Quality assurance
- Quality Control, Proficiency Test, QC
- Quality Risk Management
- Quality Target Product Profile
- Qualty Assurance Unit, QAU
- Quantiative Structure Activity Relationship, QSAR
- Quantitative Risk Assessment
- Quantitative Structure Activity Relationship, QSAR
- Quarantine
- Radiation
- Radioacctive Iodine(I-131)/ Radioactive Cesium(Cs-137)
- Radioactive contaminated food
- Radioactive contamination
- Radioactive material
- Radioactivity
- Radionuclides
- Radiopharmace utical
- Random Sample Test
- Range
- RASFF; Rapid Alert System for Food and Feed
- Rational method of analysis
- Raw Data
- Raw Material
- RCEP; Regional Comprehensive Economic Partnership
- REACH
- Real Time Release Testing
- Reasonable Maximum Exposure, RME
- Reasonable maximum exposure, RME
- Receptor
- Receptor population
- Recombinant DNA Technology-Derived Product
- Recommended Exposure Limit, REL
- Reconcilation
- Reconstituted Milk
- Recovery / recovery factors
- Reduction of Disease Risk Functionality
- Redundant Publication, Multiple Publication
- Reentry dose level, R์ด
- Reexamination
- Reference Dose, RfD / Reference Concentration, RfC
- Reference Exposure Level, REL
- Reference material
- Reference sample
- Reference Standard, Primary
- Reference Standard, Secondary
- Reference value
- Reflex development test
- Registration, Evaluation Authorization and Restriction of Chemicals
- Releasing Agent
- Relevant animal model
- Reliability
- Rendering
- Repeatability
- Repeatability conditions
- Repeatability (reproducibility) limit
- Repeatability (reproducibility) relative standard deviation (coefficient of variation)
- Repeatability (reproducibility) standard deviation
- Repeated dose toxicity study
- Replacement Test
- Representative sample
- Representativeness
- Reprocessing
- reproducibility
- Reproducibility conditions
- Reproductive and Developmental Toxicity Studies
- Reproductive and Developmental Toxicity Study
- Reproductive Toxicity
- Reproductive Toxicology
- Requirements
- Residue Specification
- Respirable particle
- Restriction Endonuclease/Restriction Enzyme
- Result
- Retention sample
- Retest Date
- Retraction Watch
- Retrospective Validation
- Return
- Revalidation (Re-Validation)
- Reworking
- RFR; Reportable Food Registry (for Industry}
- Ring test
- Risk
- Risk
- Risk Acceptance
- Risk analysis
- Risk Asesment
- Risk assessment
- Risk assessment expert committee
- Risk Characterization
- Risk characterization
- Risk Communication
- Risk Control
- Risk Evaluation
- Risk management
- Risk management authority
- Risk Profile
- Risk Reduction
- Risk Review
- Robustness (ruggedness)
- Route of Administration, Administration Route
- Route of infection
- RPM ; Routine Preventive Maintenance
- Safety assessment
- Safety Factor, SF
- Safety Pharmacology Test
- Salmonella
- Sampling frequency
- Sanitation Standard Operation Procedures, SSOP
- Scalability
- Scenario evaluation
- SCP; Single Cell Protein
- Screening
- Security
- Selectivity
- Selenium
- Self-contained area
- Sensitivity
- Sensitivity analysis
- Serious Adverse Event
- Seroconversion
- Serum Antibody Titer Test
- Serum Antibody Titer Test
- Severity
- Shareware
- Shift
- Shipping Records
- Short - Term Exposure
- Side effect
- Sievert, Sv
- Signature Lists
- Signs
- Simulant
- Simulated Product
- single-celled organism / unicellular organism
- Single Dose Toxicity Study
- Single Dose Toxicity Test
- Single Nucleotide Polymorphisms, SNPs
- Single Study Design
- Site Delegation List/Log
- Site Initiation Visit
- Site Visit
- Skin Adherence
- Skin adherence
- Skin Irritation
- Skin sensitization test
- Skin Sensitzation Test
- Slit-lamp microscope
- Slow-Food Campaign
- SML
- Sniffing
- Snoopware
- Solanine
- Solvent
- Solvent/vehicle control
- SOM; Senior Officials Meeting
- Source Code
- Source Document
- Source Term
- Species
- Specifcity
- Specific migration limit
- Specific Pathogen Free Laboratory Animal, SPF Laboratory Animal
- Specification
- Specified Risk Material, SRM
- Spill kit (kits)
- Sponsor
- Sponsor-Investigator
- Spoofs
- Spore
- Sporicidal process
- Sporocide
- SPS; Sanitary and Phytosanitary Measures
- Spyware
- SRM ; Specified Risk Material
- Stability testing
- Stabilty Testing
- Stakeholder
- Standalone System
- Standard deviation
- Standard error
- Standard of Care
- Standard operating procedure (SOP)
- Standard Operating Procedures, SOPs
- Staphylococcus aureus
- Staphylococcus aureus
- Starting Material
- State of Control
- Statement of Investigator
- Statistical significance
- Steady state exposure
- Stem Cell
- Sterile
- Sterile Area
- Sterile Product
- Sterilisation / Sterilization
- Sterility
- Sterility assurance level (SAL)
- Sterility Assurance System
- Sterility Test
- Sterilizing grade filter
- Stimulated Weanling Male Rat Assay
- Strategic Approach to International Chemicals Management, SAICM
- Strength
- Stresed Testing
- Stress Response
- Stressed Testing
- Stressor
- Stressor
- Study Coordinator
- Study for effects on embryo - fetal development
- Study of General Pharmacology
- Study of general pharmacology
- Study-Oriented Inspections
- Sub-investigator
- Subacute toxicity, Subchronic toxicity
- Subacute Toxicity Test/Study
- Subcellular Fractions
- Subchronic Exposure
- Subchronic Toxicity
- Subject
- Subject Diaries
- Subject Enrollment Log
- Subject Identification Code
- Subsidiary componentof disinfectant
- Substance
- Substantial Equivalence, SE
- Sugars
- Surrogate
- Surumi
- Surveillance
- Survival Surgery
- Susceptible Population
- Suspected Adverse Reaction
- Swap Author
- Sweetener
- Symptom Indicator
- Symptoms
- Synergism
- Synergism
- Synergistic effect
- Systematic error
- Systemic Dose
- Systemic dose
- Systemic Infections
- T-2 ๋
์
- T-2 toxin
- Tamarins
- Target
- Target
- Target Organ
- Target organ
- Target Organ Dose
- Target organ dose
- Target Population
- Target population
- Taxon
- TB testing
- TBR ; Trade Barrier Regulation
- TC; Test and Calibration
- TCID50; Tissue Culture Infective Dose 50%
- TDF; Total Dietary Fiber
- Tearoom Tradestudy
- Technology Transfer Office, TTO
- Temporally - Averaged Exposure, TAE
- Temporally - Integrated Exposure, TIE
- Temporary Acceptable Daily Intake, TADI
- Temporary Maximum Residue Limits, TMRL
- Temporary standard and specification
- Teratogenicity
- Teratogenicity
- Teratogenicity Test / Study
- Teratogenicity test / Study
- Terbufos
- Terms of Appointment
- Test chemical
- Test Guideline, TG
- Test Product
- Tetracycline
- Tetracycline
- The 3Rs; Reduction, Replacement, and Refinement
- The Best Pharmaceuticals for Children Act, BPCA
- The Citizens for Responsible Care and Research, CIRCARE
- The Family Educational Rights and Privacy Act, FERPA
- The First Author
- The Food Safety Policy Committee
- The National Comprehensive Cancer Network, NCCN
- The Office of Research Integrity, ORI
- The Safe Medical Devieces Act
- Theoretical Maximum Daily Intake, TMDI
- Theoretical yield
- Therapeutic Index
- Therapeutic Index
- Therapeutics Committee
- Thesaurus
- Thickener
- Threshold
- Tiered Testing Strategy
- Time - activity pattern
- Time Weighted Average concentration, TWA
- Tin
- Tissue Culture Infective Dose 50%, TCID50
- Tissue Culture Techniques
- Tissue Culture(s)
- Tissue-Engineered Products
- Tissues
- Titer
- TLD; Thermo-Luminescence Dosimeter
- Tmax
- Tmax
- Tolerable Daily Intake, TDI
- Toluene
- Top-down approach
- Total Diet Study, TDS
- Total effective dose equivalent, TEDE
- Total fluid intake, TEI
- Total human exposure, THE
- Toxic Dose 50%, TD50
- Toxic Dose 50%, TD50
- Toxic Equivalency Factor, TEF
- Toxic Equivalents, TEQ
- Toxicity
- Toxicodynamics
- Toxicokinetics
- Toxicological Profile
- Toxoid
- TPP; Trans-Pacific Partnership
- Traceability, Product Tracing
- Tranquilizers
- Trans fatty acids
- Transgenic Animal
- Transgenic animal
- Transient Pain
- Treatment Group
- Treatment Use of an Investigational Device
- Trial Subject
- Tributyltin, TBT
- Trichloroethylene , TCE
- True value
- Trueness
- TSE; Transmissible Spongiform Encephalopathy
- Two-Factor Authentication
- U-healthcare Medical Device
- U.S. Fish and Wildlife Service
- U.S. Patriot Act
- U.S. Trade Representative, USTR
- ULPA filter
- ULPAํํฐ
- Ultimatum Game
- Unanticipated Adverse Device Effect, UADE
- Unblinding
- Uncertainty
- Uncertainty analysis
- Uncertainty factor, UF
- Unconsciousness
- Unexpected Adverse Drug Reaction
- United States Department of Agriculture, USDA
- Unsaturated Fat
- Upper bound
- Upper Level of Intake, UL
- USDA; U.S. Department of Agriculture
- USTR; U.S. Trade Representative
- Uterotrophic Assay
- Vaccine
- Vacine
- Validated range
- Validated test method
- Validation
- Validation Master Plan (VMP)
- Validation Protocol
- Variability
- Variabilty
- Variable
- Variance
- variant Creutzfeldt - Jakob Disease, vCJD
- vCJD; Variant Creutzfeldt-Jakob Disease
- Vent filter
- Verbal Consent
- Verification
- Vertebrate
- Veterinarian
- Veterinary International Conference on Harmonization, VICH
- Viability
- Vibrio parahaemolyticus
- Vibrio vulnificus sepsis
- VICH ;Veterinary International Conference on Harmonization
- Vinyl chloride
- Virtual Private Network, VPN
- Virulence
- Vital Signs
- Vulnerable Subjects
- Warm-Blooded Animal
- Waterble Powder
- Weight-of-evidence
- Well-being of the Trial Subjects
- WHO Collaborating Center, WHO CC
- WHO Expert Committee on Biological Standardization, ECBS
- WHO Uppsala Monitoring Centre, UMC
- WHO-WPRO; WHO-Western Pacific Regional Office
- Whole body
- Withdraw
- World Health Organization, WHO
- Worst case
- Xenotransplantation
- Xenotransplantation Plant
- Yersinia
- Yersinia
- Yersinia food poisoning
- Yield, Control Accptance
- Yield, Expected
- Zearelanone
- Zero risk
- Zero Tolerance
- Zoonosis
- Zoonotic Diseases
- Zoonotic Pathogens
